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Biofilms are a ubiquitous mode of growth for bacteria and present a significant challenge 
in healthcare due to their resistant nature towards traditional antibiotic therapy. Particularly, 
biofilms can form on indwelling urinary catheters, leading to catheter-associated urinary tract 
infections, which are one of the most prevalent healthcare-acquired infections. In recent years, 
microsystems-based approaches have been developed to measure and study bacterial biofilms. In 
this dissertation, microsystems are adapted for the catheterized urinary tract environment to 
address biofilm infections in situ. Specifically, a proof-of-concept device comprised of gold 
interdigitated electrodes on a flexible polyimide substrate is fabricated and characterized in vitro. 
This substrate allows the device to conform seamlessly with the cylindrical surface of a catheter. 
Real-time impedance sensing is demonstrated, showing an average decrease in impedance of 
30.3% following 24 hours of biofilm growth. The device also applies the bioelectric effect, which 
yields an increase in impedance of 12% and the lowest biomass relative to control treatments. 
Furthermore, 3D-printed molds and commercial modeling software show that the cylindrical 
conformation does not have an appreciable impact on performance. This device is integrated with 
  
a commercially available Foley catheter using two disparate approaches: (1) integration of the 
flexible proof-of-concept device using a 3D-printed catheter insert and (2) electroless plating 
directly onto the catheter lumen. In addition to electrode integration, miniaturized electronic 
systems are developed to control sensing and treatment wirelessly with a minimal form factor. A 
smartphone mobile application is developed in conjunction with this effort, to provide a user-
friendly interface for the system. Several functions are verified with the integrated system, 
including biofilm sensing, wireless signal transmission, bladder drainage, and balloon inflation. 
To decrease the risk associated with this system for future research in vivo and in a clinical setting, 
sensing and treatment are evaluated under realistic conditions. The biochemical aspect of the 
catheterized environment is recreated using artificial urine, and the physical aspect is recreated 
using a silicone model of a human bladder and a programmable pump. A 13.0% decrease in 
impedance is associated with bacterial growth; this decreased magnitude relative to the proof-of-
concept device is due to the reduced degree of growth in artificial urine. The bioelectric effect is 
demonstrated as well, showing a reduction in planktonic bacteria of 1.50 × 107 CFU/ml and 
adhered biomass equivalent to OD590nm = 0.072 relative to untreated samples. This work provides 
a framework for developing microsystem-based tools for biofilm infection management and 
research from proof-of-concept to integrated system, particularly for CAUTI. The results 
demonstrate that the cylindrical conformation does not interfere with device sensing or treatment 
performance and that the system maintains functionality under realistic conditions, laying the 
groundwork for future in vivo and clinical testing. The system will provide in situ and real-time 
data regarding catheter biofilm colonization in a way that is not possible with existing techniques. 
Finally, the system can serve to reduce reliance on antibiotics and reduce the spread of antibiotic 
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Chapter 1: Introduction 
1.1 Motivation & Background 
Nosocomial infections remain a significant challenge in healthcare, accounting for a 
significant number of infections and contributing a large burden in terms of additional healthcare 
costs and patient-days [1]. These infections also disproportionately impact vulnerable patient 
populations in hospitals, such as the elderly or immunosuppressed individuals [2], [3]. Urinary 
tract infections, pneumonias, bloodstream infections, and surgical site infections comprise the 
most prevalent nosocomial infections [2]. Nosocomial urinary tract infections are predominantly 
associated with the use of an indwelling urinary catheter and can lead to a range of complications, 
like pyelonephritis and sepsis [4]. Despite recent research efforts, the typical approaches for 
diagnosing these infections still rely on the identification of symptoms that are often non-specific 
and urine bacterial cultures. In addition, conventional treatment relies upon administration of 
antibiotics [5]–[8]. 
The United States Centers for Disease Control and Prevention (CDC) guidelines for urinary 
catheter use do not recommend changing catheters at routine intervals. Rather, they suggest that 
catheters only be changed in response to clinical indications [9]. However, these indications 
typically only appear after an infection has developed, leading to entirely reactive interventions. 
The CDC guidelines also suggest that prophylactic antibiotics not be used routinely, due to the 
spread of antibiotic resistance [9]. This guidance represents an opportunity for improving the 
standard of care for catheterized patients and reducing the incidence of catheter-associated urinary 
tract infections (CAUTI) by identifying catheters at risk for developing these infections before 
symptoms are present. Furthermore, this guidance highlights the need to develop interventions that 
reduce the reliance on significant doses of antibiotics. 
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CAUTI development is driven by the attachment of bacteria to the catheter surface and 
subsequent biofilm formation [10]. Bacterial biofilm formation occurs when adhered bacteria at a 
threshold population encase themselves in a protective extracellular matrix, which offers numerous 
survival advantages. The matrix and the constituent cells comprise a biofilm. Bacterial biofilms 
are notably more tolerant of antibiotic therapy than their planktonic counterparts, and they can 
serve as a source of infection as bacterial cells shed and spread [11], [12]. Indwelling urinary 
catheters are inevitably colonized by biofilm, which, in turn, contribute to the development of 
CAUTI and difficulty associated with treating CAUTI. 
In this dissertation, I hope to leverage microsystems technology to develop a system that 
can help address CAUTI. Microsystems have been extensively explored in recent years as a means 
for studying bacterial biofilms [13]. Microfluidic systems have reduced the required reagent 
volumes and decreased the variability associated with biofilm growth to enable high-throughput 
and reproducible studies [14]. Microscale sensors integrated within microfluidic systems offer 
unprecedented real-time information regarding the formation of biofilm and its response to novel 
antimicrobials [13]. The real-time biofilm monitoring offered by these sensors would provide 
significant utility for the management of implanted and indwelling medical devices by providing 
continuous data regarding the degree of colonization on the surface and efficacy of interventions. 
Identification of biofilm formation on a medical device like an indwelling urinary catheter could 
give healthcare providers an indication to remove the device if feasible or implement a prompt 
targeted treatment. In particular, microscale impedance sensors comprised of a pair of 
interdigitated electrodes (IDEs) provide a simple, low-power approach for continuous biofilm 
monitoring [15], [16]. 
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In addition to detection of biofilm, microsystems can also be utilized to implement anti-
biofilm therapy. Notably, the bioelectric effect (BE) has been demonstrated in a microfluidic 
system for biofilm reduction [16]. The BE consists of a low-intensity electric field that increases 
the susceptibility of the bacteria in the biofilm to antimicrobial compounds [17]. This effect can 
significantly reduce the antibiotic dosage needed for effective biofilm removal and infection 
clearance [12]. IDEs used for biofilm monitoring can also be used to generate the electric field 
needed for the BE, enabling a dynamic, feedback-driven treatment that can be applied in response 
to real-time information regarding biofilm formation on the surface [16]. This targeted treatment 
only requires a low dose of antibiotics compared to conventional infection therapy. 
There are several barriers to widespread implementation of this approach for CAUTI 
management. Individuals involved in potentially translational research must consider how these 
planar systems can be integrated with actual medical devices that have complex surface 
geometries, such as the cylindrical lumen of a urinary catheter. They must also consider how these 
systems will operate in the physical and biochemical environment of the catheterized bladder. 
Finally, the system must be user-friendly to facilitate use by those without specific expertise. 
1.2 Summary of Accomplishments 
To my knowledge, there have been no studies that have developed integrated microsystems 
for both the detection and treatment of bacterial biofilms on urinary catheters. This type of 
approach has the potential to improve the lives of millions of patients worldwide. My research in 
this dissertation focuses on the development of integrated microsystems for biofilm monitoring 
and BE-based treatment on urinary catheters. This involves the adaptation of planar monitoring 
and treatment microelectrodes onto flexible substrates that conform to the cylindrical catheter 
surface. These flexible electrodes are then integrated with commercially available Foley catheters, 
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and the impedance sensing and BE-based treatment functionality is evaluated in a synthetic bladder 
model. The system developed in this thesis (Figure 1-1) enables care providers and researchers to 
identify biofilm colonization in real-time, which can potentially serve as a clinical indication for 
prompt treatment or catheter removal. This system also functions to administer the BE, reducing 
the reliance on antibiotics in CAUTI management. This dissertation achieves several important 
milestones towards improving CAUTI management and developing devices that address 
challenges associated with biofilm formation. The proof of concept demonstration in a cylindrical 
environment is the first flexible electrode system for biofilm detection and treatment, enabling 
these functionalities on a wide range of vulnerable surfaces. Integrating this system with the 
commercially available Foley catheter yielded a first of its kind system for managing biofilm in 
the urinary catheter environment. The custom developed printed circuit board (PCB) and mobile 
application helped make the integrated system user-friendly by providing a facile interface for 
controlling monitoring and treatment administration. The unique bladder model allowed in vitro 
characterization of this integrated system in a realistic environment to achieve a better 
understanding of how these devices will perform in the catheterized bladder. 
 
Figure 1-1: Overview schematic of integrated catheter biofilm management system: (a) Flexible sensor 
embedded in urinary catheter; (b) Wireless electronics module attached to external catheter bag; (c) 
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Smartphone application that provides an alert in the presence of biofilm and allows prompt implementation 
of treatment [18].  
1.2.1 Flexible device for biofilm sensing and treatment in cylindrical environments 
This thesis relies on previously published mechanisms for biofilm detection and treatment 
[16]. An IDE impedance sensor provides sensitive, nondestructive, and real-time monitoring of 
biofilm growth. In addition, these electrodes can be used to administer a low-intensity electric field 
that induces the BE. However, such lab-on-a-chip (LOC) systems typically utilize planar and rigid 
substrates that are incompatible with the complex surfaces of medical devices. This work 
overcomes this limitation by fabricating IDEs on flexible polyimide film that conforms seamlessly 
to the catheter surface. This flexible sensor enables real-time impedance measurements of the 
growth on the cylindrical surface, displaying similar trends to the previously reported LOC 
systems. The same IDEs allowed administration of the BE, showing a significant decrease in 
biomass adhered to the sensor. Furthermore, I examine how the device performance changes in 
the cylindrical catheter-scale geometry. COMSOL Multiphysics finite element analysis (FEA) 
simulations as well as sensor curvature experiments show relatively little change from planar to 
cylindrical surfaces at the catheter size scale. This proof-of-concept study provides the basis for 
my subsequent chapters exploring an integrated system for use in a catheterized bladder 
environment. In addition, this helps provide a more complete understanding of the relationship 
between electrode devices and the geometric space they operate in. 
1.2.2 Foley catheter-integrated system for biofilm infection management 
A key element of this thesis is the integration of a flexible monitoring and treatment device 
with a commercially available Foley catheter. The indwelling Foley catheter is one of the most 
commonly used medical devices, and is particularly vulnerable to biofilm colonization [10], [19]. 
A barrier to implementation is seamlessly integrating the electrodes with the catheters without 
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interfering with routine catheter function. This design is constrained by the design of the Foley 
catheter itself, which is highly standardized and uniform. I used a 3D-printed insert module to 
interface the sensor with the catheter, which can be incorporated post-production at a cut 
perpendicular to the catheter axis. The insert cytotoxicity was evaluated to help understand the 
safety of such a system. A custom PCB was developed to run both functions of the system via 
Bluetooth, which was controlled by a custom mobile application. The wireless control system, 
together with the insert module, comprised the integrated system. This novel system allows 
numerous future research and clinical studies regarding CAUTI and CAUTI management and 
generates insights into systems integration for medical devices. 
1.2.3 Detection and treatment in synthetic model of catheterized bladder 
One of the most significant barriers to translating in vitro LOC systems onto medical 
devices is the environment where these systems must operate. In particular, for CAUTI, this system 
must function in the catheterized bladder, exposed to urine under variable flow conditions. In this 
dissertation, I developed a synthetic bladder model in order to study the operation of an integrated 
biofilm detection and treatment system under realistic conditions. This model consists of a silicone 
bladder, artificial urine, and a programmable pump to recreate the biochemical and physical 
aspects of bacterial growth and their impact on system operation. I performed impedance sensing 
experiments using the integrated system in this model, confirming the viability of this approach 
for detecting more clinically relevant bacterial growth on catheters. Electrochemical impedance 
sensors of this type are impacted significantly by the composition of the media that they are 
immersed in, and this demonstration supports their use in this setting. The efficacy of the BE was 
also examined using this model, showing a decrease in biomass relative to untreated controls. This 
is the first study using a microsensor-based integrated system to detect bacterial growth and 
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administer BE-based treatment in a realistic setting. The accomplishments of this thesis lay the 
groundwork for future clinical studies using this integrated prototype. 
1.3 Literature Review 
1.3.1 Bacterial biofilms 
Bacterial biofilms are ubiquitous in healthcare and the environment, representing the 
dominant mode of growth for bacterial microorganisms [20]. Biofilms present a significant 
challenge because they afford bacteria significant survival advantages compared to their 
planktonic counterparts, including increased tolerance to antimicrobial therapies [11], [12]. 
Limited diffusion into the biofilm matrix and the decreased metabolic rate of the constituent 
bacteria often allows biofilm to become highly tolerant to antibiotic therapy; an antibiotic dose 
500–5000 times larger than that for planktonic bacteria is required to eliminate the biofilm and 
associated infection [11], [12]. In addition, increased horizontal gene transfer between bacterial 
cells within biofilms can help to exacerbate the spread of antibiotic resistance [21], [22]. Biofilms 
are implicated in numerous nosocomial infections, including surgical-site, bloodstream, and 
urinary tract infections often associated with medical implants, venous catheters, or urinary 
catheters, respectively [23]. Overall, these infections were estimated to be responsible for 67% of 
all hospital-acquired infections in the United States of America in 2002 [24]. Furthermore, 
bacterial biofilms are critical in the development of CAUTI, often leading to infections for patients 
with long-term indwelling catheters [10]. It should be noted, however, that not all biofilms lead to 
CAUTI [25].  
Bacteria form sessile biofilm communities when they adhere to a hydrated surface such as 
that of a urinary catheter and, at a threshold population, encase themselves in a self-produced 
extracellular matrix (ECM) consisting primarily of polysaccharides and extracellular DNA, as well 
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as lipids and proteins [11], [20]. This process is depicted in Figure 1-2. The bacteria initially adsorb 
to the surface reversibly due to physical forces. They then undergo irreversible attachment through 
bacterial appendages like flagella, fimbriae, pili, and adhesins [10], [26]. The adhered bacteria 
communicate via small molecules through a process called quorum sensing, which coordinates 
their phenotype to become a biofilm [27]. The biofilm will continue to develop into a complex, 
mature biofilm structure from which bacteria disperse throughout the environment. These 
dispersed bacteria allow additional areas of the system to be colonized by biofilm and can serve as 
a source of persistent infections if the original biofilm is not removed [11]. Persister cells with 
relatively low metabolic activity compared to the other biofilm bacteria can survive antibiotic 
therapy and can repopulate a biofilm once the treatment regimen has been concluded [28], [29]. 
This leaves catheters or medical implants susceptible to recurring infections that can only be 
treated by removing the device or implant, often requiring revisional surgery [30]. Early detection 
of the biofilm formation, along with novel antibiofilm schemes, will thus help prevent these 
recurring infections. 
Bacteria in biofilms are highly resistant to traditional antibiotic therapy compared to their 
planktonic counterparts [12]. Therefore, given the importance of biofilms in many infections, it is 
vital to consider treatments specifically designed to address biofilms. A number of different 
strategies have been explored, but these have not achieved widespread implementation for CAUTI 
care. Enzyme-based treatments, which degrade critical components of the biofilm ECM, have been 
developed for use against wound biofilms [31]. Another strategy involves interrupting the 
intracellular quorum sensing communication that bacteria use to drive biofilm formation. 
Specifically, a synthetic analog molecule of the universal signaling molecule, autoinducer-2, can 
interfere with this pathway via competitive inhibition and not allow the bacteria to express the 
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biofilm phenotype in a process known as quorum quenching [32], [33]. Quorum quenching can be 
implemented in conjunction with antimicrobials to achieve a more effective clearance [34]. The 
cells do not have the same protection that they have in a biofilm and are thus more vulnerable to 
the antimicrobial. Laser-induced nanobubbles have also been demonstrated to increase the 
susceptibility of specific biofilms to specific antibiotics, but this approach is only viable for wound 
biofilms that are not embedded deep within the body [35]. Biofilms have also been physically 
dispersed using low frequency ultrasound [36].  
 
Figure 1-2: The five stages of biofilm development: (1) initial attachment, (2) irreversible attachment and 
initial matrix secretion, (3) colony maturation I, (4) maturation II, and (5) dispersion. Each stage has an 
accompanying image of Pseudomonas aeruginosa biofilm [37]. 
Another strategy developed to treat biofilms is the BE, which combines a low-intensity 
electric field with a low antibiotic dosage for synergistic biofilm clearance [17]. Exposing the 
biofilm to the electric field leads to a dramatic decrease in the necessary antibiotic concentration, 
at least two orders of magnitude lower, needed to completely kill the cells [38]. There are several 
hypotheses that attempt to explain this phenomenon, including electrochemical generation of 
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reactive ions, electrophoretic augmentation of antimicrobial transport, and electroporation [39]. 
The BE has also been demonstrated using biocides or quorum sensing inhibitors, as opposed to 
antibiotics [40], [41]. Other antibiofilm strategies, like electroceutical wound dressings, rely on an 
applied voltage alone to generate reactive compounds that can clear biofilm [42], [43]. This 
strategy relies on higher voltages and specific material interactions that are not applicable in all 
environments, particularly indwelling medical device applications. 
1.3.2 Biofilm microsystems for characterization and treatment 
While biofilms have been studied for decades, much is still unknown [44]. Over the last 
few decades, a number of in vitro models have been developed to not only understand the biology 
of biofilms, but also to study the response of biofilm to external stimuli such as pH changes or 
exposure to antimicrobials [45]–[51]. Biofilm characterization and evaluation often relies on bulky 
external quantification equipment or laborious protocols that label components of the biofilm and 
destroy the biofilm itself [52], [53]. Therefore, there is an urgent need to develop scalable and 
reliable systems that can noninvasively quantify and characterize biofilms. Considering the broad 
variations of the real environmental settings where biofilms form (e.g. implanted devices, surgical 
tools, etc.), it is also essential to develop different characterization methods in parallel to address 
the varying clinical needs. 
Here, I give an in-depth overview of novel microtechnological approaches for biofilm 
characterization. Microscale devices and LOC sensing platforms have been considered an ideal 
solution to address this multi-faceted problem. Microfluidics provide several advantages including 
ease of fabrication, low reagent volumes and cost, tight environmental control, and high 
throughput; the implementation of microfluidic devices for biofilm studies has been discussed in 
detail by Greener et al. [14]. The review provides an in-depth view of polydimethyl siloxane 
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(PDMS) microchannel devices and the conventional metrology tools that these devices rely on. 
This section of my thesis discusses the microscale sensing technologies that can be used to evaluate 
biofilms in real time for label-free, continuous, and noninvasive characterization of biofilm 
properties such as growth, treatment susceptibility, surface coverage, biomass, metabolic activity, 
and viscoelasticity. I aim to present some of the in vitro microsystems developed over the past few 
years for biofilm testing and treatment evaluation. In particular, I review systems relying on 
optical, mechanical, and electrochemical sensing mechanisms for biofilm characterization. These 
microscale LOC systems provide numerous advantages in biomedical research and clinical 
diagnostics and could be valuable tools for investigating novel therapies. They enable functional 
integration with other technologies, leading to portability and high-throughput usage. These 
translational systems hold the potential for improved resolution, regulation, sensitivity, and 
flexibility over more traditional approaches. In addition, these devices can provide a dense array 
of sensors at the micro-scale to further reduce the necessary sample volumes, in conjunction with 
microfluidic systems, and enable real-time and non-destructive biofilm analysis. These are critical 
elements for both biological testing for drug discovery and translational biofilm detection systems. 
Studies on the development of antibiotic resistance, biofilm growth, and the role of intercellular 
communication have been improved with the use of these microsystem approaches [34], [54]–
[58]. Furthermore, it has been suggested that microdevices will reduce the necessary analysis time 
from days to the order of 2 to 4 hours with more accurate recognition of specific biological targets 
[59], [60]. 
1.3.2.1 Optical Biofilm Characterization 
Traditional biofilm studies rely on standard optical techniques such as confocal 
microscopy, crystal violet staining (CVS), or scanning electron microscopy (SEM). Many studies 
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have been performed on various biofilms using these techniques [53], [61]–[63]. However, these 
labeling procedures are often destructive to the biofilm, meaning that only end-point measurements 
are obtainable. Furthermore, these approaches do not lend themselves to integration in situ or in 
vivo for clinical applications. 
In recent years, other optical techniques that allow for real-time, non-invasive detection of 
biofilms have been developed. For example, Yawata et al. report a non-destructive, label-free 
biofilm formation monitoring system using an image analysis technique based on a modified 
confocal reflection microscopy (CRM) in a single channel, PDMS/glass microfluidic device [64]. 
To overcome the challenge of image saturation when using CRM, the authors modified the 
technique to allow for continuous manual adjustment of the detector gain while scanning along the 
Z-axis to maintain the signal intensity of cells at a constant level. This modification of CRM with 
continuous gain adjustment was termed Continuous Optimizing CRM. Using this technique, 
successful visualization of Streptococcus mutans biofilm growth was obtained every 12 hours over 
a 60-hour growth period. 
Imaging at long, 12-hour intervals yields poor temporal resolution of biofilm formation 
and growth. However, real-time chemical imaging of bacterial activities can facilitate a more 
comprehensive understanding of the dynamics of biofilm structures and functions. This has been 
demonstrated using synchrotron radiation-based Fourier transform infrared (SR-FTIR) 
spectromicroscopy in an open-channel microfluidic system by Holman et al. [65]. This imaging 
technique has been known to yield high spatial resolution and label-free vibrational signatures of 
chemical bonds in biomolecules but has been restricted in use due to the water in biofilms, shown 
to hinder SR-FTIR sensitivity. This was overcome by Holman, who developed a simple open-
channel microfluidic system with hydrophilic deep reactive ion-etched microstructures that can 
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circumvent the water-absorption barrier for chemical imaging of the developmental dynamics of 
bacterial biofilms with a spatial resolution of several micrometers. To image the biochemical 
properties and the distribution of bacteria before and after antibiotic application, the entire field-
of-view of the biofilm was divided into equal-sized squares before raster scanning and collecting 
full SR-FTIR spectra at each position, followed by scan processing using different algorithms. 
Recently, Mattana et al. reported using optical methods to generate maps of the bulk chemical and 
mechanical properties of biofilm on the microscale [66]. Biofilm matrix stiffness was determined 
using Brillouin microspectroscopy, and the composition was mapped using Raman 
microspectroscopy. Candida biofilms were grown for 72 hours and dried for one week before 
being introduced into the custom microscope setup for imaging, which collects Brillouin spectra 
using a multi-pass tandem Fabry-Perot interferometer and Raman spectra with a dispersive 
monochromator. While these were done as end-point measurements, the authors report that this 
approach could be used to probe these properties of biofilms in situ. 
Surface plasmon resonance (SPR) has been demonstrated as a means to characterize 
biofilm physiology optically. A PDMS microchannel in combination with a gold sensing surface 
on a glass prism enables real-time and label-free dissemination of the attachment and growth 
dynamics of Escherichia coli and Pseudomonas aeruginosa biofilms [67]. The change in the 
resonance peak of the light reflected from the gold sensing surface arises from a change in 
refractive index, attributable to the attached biofilm biomass. SPR offers non-destructive and 
continuous monitoring over a larger surface area than many other optical techniques (up to 1 cm2). 
Fiber optical methods of detecting biofilms have also been reported [68], [69]. One group reports 
a fiber-optic sensing system to detect the formation of electroactive biofilms – biofilms whose 
metabolism involves extracellular electron transfer that can be modulated by electrical signals [70] 
14 
 
– via electrochemical-SPR, where biofilm formation on the fiber surface leads to a measurable 
shift in the refractive index [68]. Here, the optical fiber consists of a tilted fiber Bragg grating 
coated in a nano-gold film, which acts as the working electrode. The gold-coating offers 
simultaneous electrochemical and optical SPR-based measurements of biofilm in hard to reach 
environments. 
Simpler fiber optical microsystems for biofilm detection have also been studied. Zhong et 
al. report a gold coated fiber optic sensor for detection of biofilm growth in bioreactors via fiber-
optic evanescence wave spectroscopy [71]. The fibers have a U-shaped chemically etched region, 
which was used as the exposed sensing region; the etched unclad fiber sensing region served to 
increase the evanescent field intensities. Each sensor contains an uncovered sensing probe as well 
as a parallel reference probe coated in a porous polyimide-silica film. The reference probe 
measures  light transmission through the liquid, while the sensing probe measures the transmission 
through both the liquid and the bacterial biofilm. The sensing probe was able to measure a 
significant percent decrease in transmission intensity when biofilm formed, both with and without 
flow. Phillip-Chandy et al. present a similar plastic optical fiber with its cladding removed over a 
sensitized length that measures the growth of biofilms in a closed loop water process system by 
evanescent field attenuation and intensity modulation [72]. The sensor detects biofilm build-up at 
the fiber surface by means of refractive index modulation. The authors show that the increase in 
refractive index associated with the biofilm on the surface reduces the intensity of light 
propagating in the fiber and attenuates the high order propagation modes. 
Although the aforementioned methods provide high sensitivity, they require extensive data 
collection and processing. Thus, simpler methods of imaging that require less or almost no data 
processing have been suggested. Biofilm thickness in microfluidic channels can be determined 
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using simple off-the shelf optoelectronic devices, such as photodiodes or charge-coupled device 
(CCD) arrays, shown in Figure 1-3 [54], [73]. Here, the optical density gives a direct measure of 
the biofilm thickness, while the CCD array functions in deriving the spatiotemporal thickness of 
the biofilms along the length of the channel. 
 
Figure 1-3: Schematic of the microfluidic biofilm observation, analysis, and treatment (Micro-BOAT) 
platform. The platform is capable of performing six experiments in parallel on a single chip. Real-time 
biofilm monitoring is achieved via the measurement of biofilm optical density (OD) using CCDs and a 
tuned light emitting diode (LED) source (not shown) [73]. Reproduced with permission from [73]. 
1.3.2.2. Mechanical Biofilm Characterization 
Microsystems that utilize the inherent mechanical properties of the device to measure the 
mass loading onto the device surface have also been developed for accurate biofilm sensing in 
real-time. These microsystems typically employ a thin-film piezoelectric material, which can 
provide an electrical response corresponding to the amount of mass loading. The most commonly 
researched mass loading sensors include the quartz crystal microbalance (QCM), quartz tuning 
fork oscillators, and surface acoustic wave (SAW) sensors. 
The QCM is a sensitive technique used extensively to study the solid-liquid interface. QCM 
measurements are based on a shift of the quartz crystal’s resonant frequency due to interactions 
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with solution components [74]. QCMs have also been used to study and characterize biofilm 
growth and removal in real-time. Reipa et al. used the QCM in conjunction with optical techniques 
to monitor the long-term (6 days) growth of biofilms in a reactor [75]. The authors utilized a 
parameter, the ratio of change in resistance to change in frequency that reflects changes in the 
viscoelastic properties of the biofilm, to monitor its growth in low nutrient environments in real-
time. In parallel, the optical technique of white light reflectance off the surface of the QCM gold 
electrode was used to determine the biofilm thickness. Similarly, Castro et al. used a QCM to 
analyze the viscoelastic properties of Staphylococcus epidermidis and Escherichia coli, identifying 
an increase in shear modulus as a distinctive characteristic in biofilm formation [76]. 
QCMs have been combined with dissipation monitoring, known as QCM-D, to 
continuously monitor in situ bacterial cell attachment and growth of biofilms [77]. Using this 
method, Schofield et al. showed that biofilms formed under continuous flow had greater biomass 
and were more viscoelastic, or softer, than biofilms that were seeded without flow and grown with 
flow. The energy losses represented by the increases in the dissipative factor (D) indicated an 
increase in ‘softness’ of the attached cells. Additionally, the ratio of the dissipative factor to 
frequency or D/f was used to provide information on how viscoelasticity changed per unit mass. 
These studies allowed not only for the detection of biofilm monitoring during the various stages 
of growth and treatment with antibiotics or antibacterial agents, but also the continuous monitoring 
of the properties of cells while establishing that flow conditions over cells on the surface are 
important in creating biofilms with greater complexity and stability. More recently, this technique 
has been used to assess cell-surface interactions as well [78]. Marcus et al. combined this 
technology with a fluorescent microscope and camera to monitor kinetics of cell adhesion over 
time. Two different surfaces, silica (SiO2) and polyvinylidene fluoride, which are hydrophilic and 
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hydrophobic, respectively, were used to test the role of surface wettability on biofilm formation 
[78]. Olsson et al. studied the adhesion of a series of Streptococcus salivarius mutants, each 
possessing various surface appendages of known lengths, as a function of time using QCM-D. The 
experimental results were used to further understand and interpret the frequency change and 
dissipation signal due to the complex interactions within the 250 nm between the substratum and 
the bacterial cell surface [79]. The same group also showed that while only bacterial attachment 
to the QCM shifts the frequency in the positive direction, ECM-generating strains of bacteria that 
form biofilms elicit a frequency shift in the negative direction [80]. 
Waszczuk et al. developed disposable piezoelectric quartz tuning fork mass sensors to 
evaluate bacterial biofilm growth [81]. The authors demonstrate the use of this low frequency 
quartz tuning fork sensor to detect the dynamics of the various phases of Pseudomonas aeruginosa 
biofilm. Unlike QCMs, the effective mass of molecules adhering to a quartz tuning fork surface is 
not equal to real mass and is only a fraction of the real mass. However, the real mass of bacterial 
biofilm grown on the tuning fork can be estimated using the tuning fork resonant frequency shift. 
The authors thus validate the use of the tuning fork as a crystal oscillator, which experiences a 
change in frequency due to the change in mass resulting from biofilm growth on the sensing area. 
The same group demonstrate the use of quartz tuning forks to detect the viscosity and density of 
biofilms and report the development of a quartz tuning fork ring-down system, based on the 
modulated excitation signal technique to provide the quartz tuning fork excitation, for detecting 
the formation of Pseudomonas aeruginosa biofilm in situ [82]. The authors calibrate the quartz 
tuning fork ring-down system by measuring oscillation results in reference liquids so that unknown 
densities and viscosities could be determined. This system was also used to successfully measure 
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viscosity of the biofilm when subjected to different concentrations of the antibiotic ciprofloxacin 
at distinct incubation times. 
SAW devices are an alternative platform to the QCM and quartz tuning fork, with the 
advantages of easier integration into array systems, simpler miniaturization, and significantly 
increased sensitivity due to the surface-guided nature of the mechanical wave and a higher 
operating frequency [83]–[85]. Berkenpas et al. developed a shear horizontal SAW device with 
stable temperature control and high frequency phase measurements for bacterial detection [86]. 
Escherichia coli were cultured and applied to the antibody-coated sensing surfaces, and the 
transmission coefficient phase of the biosensor was monitored continuously using a network 
analyzer. Sensitive real-time detection of biofilm growth was also demonstrated using a SAW 
sensor that is integrated with the BE treatment system [87], [88]. A schematic of the SAW sensor 
integrated with electrodes for the BE treatment application is shown in Figure 1-4. Real-time 
detection of biofilms is achieved by measuring the resonant frequency shift of the SAW system, 
which is a function of the total biomass adhered to the surface of the sensor and the change in 
viscoelasticity. As both biofilm growth and BE treatment cause a change in the adhered biomass, 
they can be measured in real-time by monitoring the resonant frequency of the system. While the 
described mechanical systems feature high sensitivity to mass loading, these sensors are 
constrained by the required piezoelectric materials that limit the viability of integration with 




Figure 1-4: Schematic of a SAW sensor passivated with Al2O3 and integrated with BE treatment 
capabilities [87]. Reproduced with permission from [87]. 
1.3.2.3. Electrochemical Biofilm Characterization 
Electrochemical biosensors are a well-studied class of sensors and are the first widely 
successfully commercialized biosensors [89], [90]. These are broadly divided into two categories 
according to the operating principle governing their method of measurement: impedimetric/non-
faradaic and faradaic (potentiometric, amperometric) transducers.  
Impedimetric Microsystems: Impedance based techniques have been used as a method of 
transduction for detecting and quantifying bacteria. Specifically, impedance microbiology (IM) 
has been used for decades to detect the presence of microorganisms in samples in the food industry, 
environment, and health care [91], [92]. In IM, the change in impedance is measured using a pair 
of electrodes that is submerged in the culture medium. To detect bacterial growth in real-time, the 
relative or absolute change in conductance, impedance, or capacitance of the solution are measured 
at a given temperature. While classical impedance microbiology uses either direct or indirect 
measurement techniques for measuring the impedance change of the media, several studies have 
found that the total impedance change during bacterial growth consists of two components that 
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can be measured at different frequency ranges: (i) impedance change contributed by the media and 
(ii) impedance change contributed by the electrode/electrolyte interface, also known as the 
electrochemical double layer (EDL) impedance. This electrochemical impedance measurement is 
generally a non-faradaic process that does not involve charge transfer at the electrode surface, 
which contrasts with the faradaic – amperometric or potentiometric – approaches discussed in the 
next subsection. The EDL impedance dominates at lower frequencies (typically < 10 kHz) while 
the growth medium impedance becomes more dominant at frequencies above 10 kHz. A simple 
equivalent circuit model, in which a resistor, Rs, is in series with two EDL capacitors, each of value 
Cdl, can be used to understand the frequency dependence of both elements on the overall 
impedance. The impedance (Z) of the circuit can be mathematically expressed as equation (1.3.1) 
below: 
|𝑍| =  √𝑅𝑠





     (1.3.1) 
where f is the frequency, Rs is the solution resistance, and Cdl is the EDL capacitance at the 
electrodes. 
Similarly, IDEs – a conventional two-electrode system configuration at miniaturized scales 
– have been used for sensing biological samples via impedance and require smaller sample 
volumes while providing a higher signal to noise ratio, faster reaction kinetics, and faster 
attainment of a steady-state relative to other microelectrode approaches, along with a relatively 
low power requirement [59], [93]–[96]. The equivalent circuit model, mathematically expressed 
in (2.1), remains valid for the case of the IDEs. However, the frequency ranges over which the 
EDL capacitance and the solution resistance are dominant may change with the electrode spacing 
and width. Yang et al. demonstrated the use of IDEs for sensing bacterial growth; specifically, the 
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growth induced a 30% change in the EDL capacitance with almost no change in the solution 
resistance (-0.58%) [95]. IDE-based systems can be advantageous over conventional electrode 
systems in that the IDEs can measure the change in the EDL capacitance to monitor bacterial 
growth. 
In biofilms, both the cells and the ECM within the biofilm serve as dielectric materials and 
thereby are responsible for its electrochemical impedance that varies with the time, composition, 
or metabolic state of the biofilm. Hence, bacterial biofilms grown on the surface of microelectrodes 
can be modeled as an electrical circuit. One such equivalent electrical model is presented in Figure 
1-5 (a)-(c). Figure 1-5 (a) presents the electrical model of a sterile culturing media that does not 
contain any bacteria. Figure 1-5 (b)-(c) presents a simplified series and equivalent parallel 
electrical model for when biofilm and ECM grow between the two electrodes. In the circuit, the 
parameters represent the following: Cdl is the EDL capacitance, Rsol is the resistance of the media 
without bacterial cells, and Cbio and Rbio are the capacitance and resistance of the biofilm, 
respectively. The ideal circuit model for a given situation can be determined by comparing these 
models to experimental results. When bacterial metabolism causes a change in the first two 
parameters, the impedimetric response of the culture changes proportionally [97]. 
The magnitude of the impedance of the three electrical circuits shown in Figure 1-5 can be 
calculated using equations (1.3.2), (1.3.3), and (1.3.4) listed below. Paredes et al. calculated the 
numerical values of the various parameters by fitting these equations to experimental data obtained 
for Staphylococcus epidermis biofilms [97]. 
𝑍(𝑎) =  𝑅𝑠𝑜𝑙 +  
2
𝑗𝜔𝐶𝑑𝑙
       (1.3.2) 
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𝑍(𝑏) =  𝑅𝑠𝑜𝑙 +  𝑅𝑏𝑖𝑜 +  
2
𝑗𝜔𝐶𝑑𝑙
 +  
1
𝑗𝜔𝐶𝑏𝑖𝑜
  (1.3.3) 
𝑍(𝑐) =   
𝑅𝑠𝑜𝑙 𝑅𝑏𝑖𝑜
𝑅𝑠𝑜𝑙 + 𝑗𝜔𝑅𝑠𝑜𝑙𝑅𝑏𝑖𝑜𝐶𝑑𝑙+ 𝑅𝑏𝑖𝑜
 +  
2
𝑗𝜔𝐶𝑑𝑙
   (1.3.4) 
 
Figure 1-5: Cross-section schematic of electrical circuit model of a pair of electrodes. (a) Circuit model for 
sterile culture media before inoculation with bacterial cells. Equivalent (b) series and (c) parallel circuit 
models after biofilm and ECM formation [13]. 
By fitting these or other equivalent models to the experimental data, specific electrical 
parameters of the system can be tracked and used to accurately sense the onset of biofilm growth 
as well as the growth over time. For example, Liu et al. utilized an IDE based impedance sensor 
and an equivalent circuit model to track changes in the resistance and capacitance of Escherichia 
coli and Salmonella biofilms over time [98]. 
Impedimetric techniques have emerged as one of the most common methods for biofilm 
detection and characterization [92], [99]–[101]. Stöckl et al. employed a three-electrode setup, 
which separates reference and counter electrodes for  a more stable electrode system than the two-
electrode approach for impedance measurements, to determine the bacterial adhesion properties of 
Shewanella oneidensis biofilms using electrochemical impedance spectroscopy (EIS) [102]. EIS 
involves measuring the impedance of a sample over a range of frequencies to gain a greater 
understanding of the resistive and capacitive characteristics of the sample. The flow cell and 
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electrode setup developed by Stöckl et al. allows parallel confocal laser scanning microscopy in 
addition to EIS for biofilm characterization. 
A microfluidic multi-channel device based on the principles of bifurcation has been 
developed that allows for spatial segmentation of biofilms with the ability to perform multiple 
experiments on the same chip (Figure 1-6) [16]. The sensor-treatment system is comprised of IDE 
electrodes that detect biofilms using traditional impedance measurements and performs treatment 
using the BE. In studies performed with this device, the BE treatment was applied based on the 
state of the biofilm, accessed by comparing the measured impedance values with a user-set 
impedance change threshold. Thus, this system allowed for continuous real-time monitoring of 
biofilm growth, while simultaneously being programmed to administer treatment when necessary.  
More sophisticated impedimetric systems, with capabilities to monitor more than one 
parameter simultaneously, have also been reported. Bruchmann et al. reported a multi-parametric 
sensor, that uses both non-faradaic (EIS) and faradaic (amperometric current) measurements 
(discussed in the following subsection) within a multi-channel microfluidic platform to measure 
biofilm formation and activity, respectively [103]. Here, gold IDEs or circular electrodes were 
used to detect Stenotrophomonas maltophilia and Pseudomonas aueruginosa biofilms as well as 
complex mixed population biofilm formation, exoenzymatic activity, and their responses to 
disinfectant and anti-biofilm reagents, thus making this sensor a qualified tool for assessing biofilm 
formation in specific environments. However, a large experimental variation between biofilms was 
observed. Similarly, the sensor developed by Estrada-Leypon et al. used multiple sets of electrodes 
not only to detect biofilm formation and activity, but also to measure dissolved oxygen, Na+, K+, 
and pH levels within the biofilm [104]. This was achieved by using two sets of IDEs along with 
punctual electrodes. Carminati et al. utilized an impedimetric microsensor for measuring biofilm 
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formation along with sensors for pH, conductivity, and temperature for pipe water quality 
monitoring [105]. Furthermore, Tubia et al. demonstrated that IDE-based impedimetric sensors 
functionalized with antibodies could be utilized for detecting specific biofilm, in this case 
Brettanomyces bruxellensis [106]. 
Potentiometric and Amperometric Microsystems: Faradaic electrochemical techniques 
including potentiometric and amperometric methods have also been employed for real-time 
biofilm sensing. These types of measurements allow monitoring of faradaic current, generated by 
the reduction and oxidation of a redox species in contact with a solid electrode. It has been shown 
that during the first steps of bacterial adhesion, there is a charge transfer between the cells and the 
substrate [107], [108]. Bacterial cells generate a variety of molecules (e.g. pyocyanin, phenazine-
1-carboxylic acid, etc.) that possess electrochemically active groups that can react with the free 
electrons of the surface. Electrochemical techniques enable tracking of this behavior, making it 
possible to study them, and hence, detect bacterial presence at the initial stages of adhesion and 
biofilm formation. 
Becerro et al. achieved this by developing a thin-film sensor that was designed for cyclic 
voltammetry (CV) and differential pulse voltammetry (DPV) measurements [109]. The authors 
use a four-microelectrode configuration, which comprises two gold working electrodes along with 
a platinum counter electrode and a platinum pseudo-reference electrode. This configuration 
provided higher sensitivity, a lower ohmic drop, and faster achievement of a steady-state current 
than a two-electrode configuration [110], [111]. Staphylococcus epidermidis biofilm presence was 
detected within two hours after initial inoculation using CV and one hour after with DPV. An 
increase in both the current signal and the three recorded redox peaks were observed proportionally 
to biofilm growth. Additionally, the CV and DPV measurements yielded information about the 
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specific stage of growth of the biofilm, indicated by different oxidation and reduction peaks, along 
with shifts in the overall current value. Similarly, Fysun et al. used CV and square-wave 
voltammetry to assess Paenibacillus polymyxa attachment [112]. 
Other researchers use electrochemical sensing to spatially monitor the chemical 
distribution in biofilms, which can help characterize the biochemical processes and regulation 
involved in cellular community development. Bellin et al. used an electrochemical camera chip 
capable of simultaneous spatial imaging of multiple redox-active phenazine metabolites, which 
are associated with biofilm activity and colonization via square wave voltammetry [113]. The chip 
consists of multiplexed electrodes that enable potential-sweep-based electrochemical imaging of 
whole Pseudomonas aeruginosa biofilms. Using both wild-type and mutant biofilms, the authors 
were able to confirm the spatial location of different phenazine metabolites. Additionally, this 
method lends itself to detecting unanticipated compounds. 
Thus, electrochemical biosensors are a promising class of microsystems that lend 
themselves to miniaturization, require low power, and are extremely sensitive to small changes in 
the environment. These advantages make this class of sensors a serious candidate for real-time 
biofilm detection in medical devices or other systems. None of the systems described, however, 





Figure 1-6: Photograph of the multi-channel microfluidic device with IDEs for biofilm sensing and 
treatment using the BE [16]. Adapted with permission from [16]. Copyright 2017 American Chemical 
Society. 
1.3.3 Catheter-associated urinary tract infection (CAUTI) & CAUTI management 
CAUTI is one of the most prevalent nosocomial infections, accounting for over 25,000 
cases in United States’ hospitals in 2018, according to the CDC [1]. In addition, the healthcare 
costs of CAUTI were estimated to be around $450 million in the United  States in 2007 [114]. 
CAUTI is driven by the colonization of the catheter by bacterial biofilms [115]. An indwelling 
urinary catheter is initially coated with a conditioning layer of host proteins from the urine which 
promote bacterial adhesion [10]. Bacteria can attach and begin to colonize the catheter during 
catheter insertion or by migrating along the inner lumen or catheter-urethra interface [116]. These 
bacteria are often fecal contaminants or part of the skin microbiome, but they can also originate 
with the healthcare providers [10]. Once attached, the bacteria grow and form a protective biofilm, 
depicted in Figure 1-7 [10]. CAUTI can lead to severe complications such as blockages, 





Figure 1-7: Biofilm development process in urinary catheters [10]. Reproduced with permission from [10]. 
Guidelines issued by the CDC recommend that indwelling urinary catheters not be changed 
at routine intervals, but rather based on clinical indications, such as infection or obstruction [9]. 
However, many clinical indications, such as conventional bacterial cultures, take hours or days to 
identify potential infections [120]. Furthermore, healthcare practitioners typically wait for 
symptoms of an infection, such as fever, pain, or dysuria, to develop before ordering cultures [5]. 
This time can allow infections to progress significantly; identification of infection risk (i.e. biofilm 
colonization), leading to prompt catheter removal or treatment, is important for CAUTI 
management. However, it is important to note that not all catheter biofilms lead to CAUTI [25]. 
Numerous strategies have been explored to reduce the incidence of CAUTI by modifying 
the surfaces of indwelling catheters. The catheter surface can be made to kill adherent bacteria by 
displaying or eluting antimicrobial molecules. Notably, chemical surface modifications such as 
impregnation with antiseptics, antibiotics, or metal ions have shown some efficacy in research but 
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have revealed inconsistent results in clinical practice [121], [122]. Furthermore, antibiotic-infused 
catheters are not desirable, as widespread antibiotic use increases the risk of selection for antibiotic 
resistance [5]. Catheter surfaces can also be modified to interfere with bacterial cells’ ability to 
adhere. Notably, microscale topography, designed to mimic shark’s skin, has been shown to reduce 
bacterial attachment and delay biofilm formation [123]. Similarly, liquid-infused surfaces have 
been shown to reduce the degree of biofilm formation on catheter-like materials [124]. Despite 
widespread efforts to mitigate the challenges associated with CAUTI, it remains a large-scale 
problem, demanding new and innovative approaches for effective management. 
1.3.4 Catheter-integrated microsystems 
An overarching theme in this thesis is the integration of microsystems with a urinary 
catheter to achieve effective biofilm management. An array of different microsystems have been 
integrated with catheters. However, none allow monitoring and treatment on urinary catheters for 
CAUTI mitigation. Microscale pressure sensors were one of the first microsystems integrated with 
catheters [125]. These were incorporated onto the tip of a vascular catheter to measure pressure in 
the heart. Other systems integrated with vascular catheters include flow sensors [126], glucose 
sensors [127], and magnetic actuators for biofouling removal [128]. Many sensors have been 
adapted for use on urinary catheters as well. Patents have been published describing incontinence 
[129], temperature [130], [131], and pressure [132] sensors integrated with urinary catheters. 
Temperature sensor-integrated Foley catheters, in particular, are currently commercially available 
and have achieved clinical use [133]. Other research groups have integrated pH-sensitive materials 
with urinary catheters to enable colorimetric detection of Proteus mirabilis infection [134]–[136]. 
In one variation of this approach, a catheter is coated in a pH-sensitive polymer that degrades when 
the pH rises above a threshold and releases an indicator dye [134]. While this may work for Proteus 
29 
 
mirabilis, this fails to account for the broad range of organisms associated with the majority of 
CAUTIs [116], [137]. To the best of my knowledge, no previous work integrates a more general 
biofilm or bacterial growth sensor with a urinary catheter. In addition, such a sensing approach has 
not been combined with BE treatment in this application to form a dynamic biofilm monitoring 
and removal system. 
1.4 Structure of Dissertation 
The first chapter of this dissertation has focused on the background and motivation for this 
work, introducing the challenge of CAUTI and a microsystems-based approach for addressing it. 
The second chapter describes the development and testing of a proof-of-concept flexible device 
for both impedance-based sensing and BE treatment of biofilm in a cylindrical catheter-like 
environment. Chapter three focuses on systems integration to incorporate the sensing and treatment 
functionalities with a standard, commercially available Foley catheter. Chapter four discusses the 
performance of the integrated system in a realistic bladder model. Finally, the key contributions of 




Chapter 2: Impedimetric Sensing and Bioelectric Effect Treatment of 
Biofilm in a Cylindrical Environment 
The first step in developing a microsystem-based approach for managing CAUTI is 
adapting existing LOC systems for use in geometrically complex environments, particularly the 
cylindrical geometry of the lumen of a urinary catheter. I relied upon the planar impedance-based 
sensor system that also incorporates BE-based biofilm treatment developed previously in our 
group [16], [41]. This design had to be adapted to a substrate that is conformable to the cylindrical 
surface but is also compatible with the fabrication techniques required for the IDE design. 
Furthermore, the device must maintain its sensing and treatment functionality when placed in the 
catheter-scale cylindrical environment. In this chapter, I produce a proof-of-concept device for 
biofilm monitoring and treatment in urinary catheters. First, I develop a fabrication process for 
IDEs on a flexible substrate that enables seamless conformation of the electrodes with 
geometrically complex surfaces. Then, I demonstrate that these electrodes can detect the growth 
of Escherichia coli biofilm in real-time via impedimetric sensing. These same electrodes are also 
shown to be capable of administering the electric field needed for the BE treatment of the biofilm. 
Lastly, the impact of varying curvature on device performance is also examined experimentally 
and using commercial modelling software. 
I gratefully acknowledge Dr. Luke Beardslee for his help developing this fabrication 
process. I also must acknowledge Sam Preza for his help performing the COMSOL modeling. 
2.1 Flexible Sensor for Impedimetric Biofilm Sensing on Complex Surfaces 
Sensor systems fabricated on flexible substrates have drawn significant interest in recent 
years due to their potential for enabling integration in a diverse array of applications. Flexible 
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substrates allow devices to conform seamlessly and operate on complex 3D surfaces without 
interfering with the function of the target system. Highly deformable biocompatible polymeric 
substrates are specifically of interest for wearable or implantable devices. Thin polyimide films 
have been utilized extensively to fabricate conformal humidity sensors [138], tactile strain sensors 
[139], transistors [140], neural probes [141], etcetera, as it is robust with regards to fabrication as 
well as being highly flexible and biocompatible [142]. Parylene-C films have also served as 
flexible substrates, particularly for implantable probes or wearable devices [143], [144]. 
Elastomers, including PDMS, are also popular. PDMS fabrication is highly robust and flexible, 
enabling a wide range of potential devices and applications. Examples include wearable pulse 
sensors [145], electrochemical sensors [146], or stretchable circuit components [147]. Flexible 
substrates have also been interfaced with off-the-shelf electronic components [144]. The breadth 
of flexible substrates that have been utilized in recent years provides a diverse array of options 
when approaching the multidimensional surfaces susceptible to biofilm formation regarding 
fabrication, chemical and biological compatibility, and integration. 
In this section, I describe a flexible impedance sensor capable of detecting biofilm 
formation in a cylindrical setting, specifically in the interior lumen of a catheter. The device is 
comprised of gold IDEs fabricated on a flexible polyimide film, allowing the electrodes to conform 
to the cylindrical inner surface of the catheter to sense biofilm in real-time. The highly flexible 
nature of the thin polyimide film encourages facile integration with the cylindrical architecture of 
the catheter lumen, and it is both biologically inert and compatible with microfabrication processes 
[142]. The platform was characterized in a custom flow system consisting of a catheter tube 
integrated with the device on which biofilm was grown. I characterized the impedance sensor 
response in vitro using a benchtop potentiostat. Both the end-point and real-time impedance 
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characteristics provide a clear picture of the viability of this device for continuous monitoring of 
the catheter surface with regard to biofilm colonization. CVS correlates the impedance change 
with the biofilm biomass to corroborate the relationship between biofilm growth and flexible 
sensor response. 
2.1.1 Materials and methods 
The electrodes were patterned on the polyimide substrate using a standard 
photolithography process. A 25.4 µm thick Kapton HD polyimide film (McMaster-Carr) was 
affixed to the surface of a 4-inch silicon wafer via heat-release tape (Semiconductor Equipment 
Corp.). A photolithography step with a positive photoresist (PR) (Shipley 1813 resist, Microchem) 
defined the IDE geometry on the polyimide substrate using the transparency photomask depicted 
in Figure 6-1 in Appendix A. Each patterned polyimide substrate was then exposed to oxygen 
plasma for 1 minute at 200 W immediately prior to metal deposition to improve adhesion 
(Branson). 20/200 nm of chromium/gold was deposited on the wafer via e-beam evaporation 
(Angstrom Engineering), with the chromium serving as an adhesion layer. Electrode fabrication 
was completed via a lift-off step in acetone for 1 minute. The electrode patterned polyimide 
substrate was removed from the wafer by heating to 150 °C on a hot plate, prompting release by 
the tape. The fabrication process is depicted in Figure 2-1. Each device consisted of gold IDEs 
with width and spacing of 300 µm over a 10 mm × 40 mm footprint, connected to 30 mm-long 
gold leads. The device schematic is shown in Figure 2-2 (a), along with a photograph of the actual 




Figure 2-1:  Fabrication process flow: (1) adhere polyimide film to wafer, (2) pattern PR, (3) metal 
deposition, (4) lift-off, and (5) release from tape at 150°C [148]. © 2018 IEEE 
 
Figure 2-2: (a) A schematic of the flexible platform showing 1) the flexible 25.4 µm polyimide substrate, 
2) gold leads for interfacing the sensor with a potentiostat, and 3) gold IDEs with 300 µm width and spacing 
over a 10 × 40 mm2 footprint. (b) An optical image of the device interfaced with the interior lumen of the 
catheter tube (inner diameter of 4.5 mm). The device is seamlessly integrated onto the curved surface with 
no signs of degradation, highlighting the advantage of the flexible platform [148]. © 2018 IEEE 
This proof-of-concept system was tested in a custom-designed flow system, depicted in 
Figure 2-3. This flow system consisted of two 500 ml flasks, with one serving as a media reservoir 
and the other as a waste container. The flasks were connected to an 11 cm section of 18 Fr 
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intermittent catheter tubing (Allegro Medical) with the sensor adhered. The flasks were sealed with 
rubber stoppers, with two holes for fluidic connections. Uncured PDMS (Dow-Corning) mixed at 
a 10:1 ratio of base to curing agent was coated on the interior of the catheter tube by introducing a 
large drop at the inlet and spreading it over the entire surface with a wooden applicator rod. The 
flexible device was introduced while the surface was coated in uncured PDMS. Throughout the 
process of adhering the device to the inner surface of the catheter, the tube was held in a vertical 
position to ensure any excess PDMS would flow away from the IDEs. Then, the PDMS was cured 
for 3 hours at 60 °C to fix the polyimide substrate in place. Once cured, fluidic connections were 
assembled with tygon tubing and luer connectors (Cole-Parmer), interfacing the sensor and 
catheter section with the media and waste reservoirs. The media container was filled with 500 ml 
of Lysogeny broth (LB) media (Sigma). The catheter/sensor system, tubing, and both reservoirs 
were autoclaved for 40 min at 121 °C for sterilization. The components were then connected in a 
sterile biosafety cabinet to prevent contamination. The outer diameter of the tubing and the inner 
diameter of the catheter tube are such that the connection is friction sealed. The electrical 
connections were made by sandwiching aluminum foil strips in between the contact pads and the 
tygon tubing. The friction seal helped to hold the foil contact in place and isolate it from the 
solution being flowed. The foil extended beyond the catheter tube on the outside of the tygon 
tubing, where it could interface with the potentiostat via alligator clips. Following assembly, pure 
LB media was introduced throughout the flow system for conditioning to remove air pockets. An 
air break was included to prevent bacteria traveling from the catheter into the sterile media 
reservoir. The reservoirs were connected to 0.2 µm syringe filters (VWR) to equalize the pressure 
during flow and maintain sterility. Flow was driven by a syringe pump (Cole Parmer, 74900) in 
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withdrawal mode at 7 ml/h. The sensor/catheter system was maintained at 37 °C in a closed 
incubator, to simulate an inserted catheter. 
 
Figure 2-3: Custom flow system setup for testing in situ biofilm detection and BE treatment in a catheter 
model [148]. © 2018 IEEE 
Prior to each experiment, Escherichia coli K-12 W3110, a wild-type strain exhibiting a 
biofilm-forming phenotype, were incubated in 5 ml of LB media for 20 hours at 37 °C in an Innova 
4000 incubator shaker (New Brunswick Scientific) set to 250 rpm. The bacterial solution was then 
diluted to an OD600 nm of 0.25 (corresponding to 6 × 10
7 CFU/ml). 1 ml of the diluted bacterial 
suspension was injected directly into the flow system connected to the catheter-sensor flow system. 
Bacteria were allowed to attach to the catheter and sensor surface for 2 hours under static (no flow) 
conditions, constituting the ‘seeding’ phase. Following seeding, fresh LB media was flowed 
through the system at 7 ml/h for 24 hours, constituting the ‘growth’ phase. Time-lapse images of 
biofilm growth were acquired using a digital camera (Sony Alpha 6000) at 0, 6, 12, and 24-hour 
time intervals. Throughout the experiment, impedance data were collected via a potentiostat 
(model 660D, CHInstruments) running through a previously-developed MATLAB-based 
graphical user interface [16]. In order to evaluate this device as a real-time monitoring tool, the 
impedance at 100 Hz was measured every 2.25 minutes. The impedance spectra from 10 Hz to 106 
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Hz at 50 mV was determined at four different phases of the growth experiments: conditioning with 
media before the addition of bacteria, seeding, 5 hours into growth, and 24 hours into growth. 
These were plotted using the Matlab (Mathworks) program in Appendix B.1. This allowed 
characterization of the impedance response due to biofilm growth. The impedance spectra could 
be compared to the equivalent circuit models in section 1.3.2.3 to identify the specific parameters 
driving the sensor response using the Matlab program in Appendix B.2. The relative percentage 
change in impedance was calculated and compared between an unseeded control and a biofilm 
sample using (2.1), where Z is the system impedance at the time of measurement and Zinitial is the 
impedance at t = 0. One-way analysis of variance (One-way ANOVA) was performed to evaluate 
the significance of the changes in impedance. 
% 𝑐ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑍 = (𝑍 − 𝑍𝑖𝑛𝑖𝑡𝑖𝑎𝑙)/𝑍𝑖𝑛𝑖𝑡𝑖𝑎𝑙 × 100   (2.1)     
2.1.2 Flexible biofilm impedance sensor characterization 
Impedance spectra were obtained and compared at four sequential phases during the 
biofilm growth process. The average impedance spectra are shown in Figure 2-4 (a)-(b), and the 
percentage change at each phase relative to the initial impedance measured during the conditioning 
phase is shown in Figure 2-4 (c)-(d) for 10 Hz, 100 Hz, 1 kHz, 10 kHz, and 100 kHz. The control 
sample in Figure 2-4 (a) was characterized by a relatively uniform increase in impedance across 
all frequencies, with a small positive shift apparent after 5 hours and a more significant shift after 
24 hours. By contrast, samples with biofilm in Figure 2-4 (b) were characterized by decreases in 
impedance at lower frequencies, particularly below 5 kHz. The change was negligible after 5 hours 
of growth. However, after 24 hours of growth, a mature biofilm had formed, and the impedance 
spectrum had shifted at lower frequencies. The control showed an increase in impedance of 20-
30% at each of the representative frequencies at the end of the 24 hours period (Figure 2-4 (c)). 
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This increase was irrespective of frequency and was attributed to the formation of small bubbles 
near the sensor surface due to the permeability of the silicone to air, which allowed air to diffuse 
through the tube walls. In addition, the media reservoir was being maintained at room temperature, 
and bubbles in the LB media experienced thermal expansion when they flowed into the catheter at 
37 °C. The formation of small bubbles was further encouraged by the negative pressure created in 
the tube used to drive the LB media flow. This encouraged bubbles to expand with air from outside 
the tube. After 24 h of biofilm growth, there was a decrease in impedance of 5-20% at 1 kHz and 
below (Figure 2-4 (d)). Overall, the spectra showed significant differences in relative change in 
impedance with 24 hours of biofilm formation (Figure 2-4 (d)) compared to the bacteria free 
control (Figure 2-4 (c)) at 10 Hz (p = 0.1901), 100 Hz (p = 0.0947), 1 kHz (p = 0.0553), 10 kHz 
(p = 0.0020), and 100 kHz (p = 0.0715). Overall, this result suggests that the frequency-dependent 
decrease arises as the biofilm alters the capacitive components of the circuit, which are dominant 
at lower frequencies. 
When comparing the experimental results to the equivalent circuit model equations 1.3.3 
and 1.3.4, it becomes apparent that the series model (1.3.3) of biofilm formation is more 
appropriate in this case. For this model, at higher frequency, the capacitive terms disappear. This 
leads to a plateaued value approximately equal to the sum of the biofilm resistance and solution 
resistance at higher frequency (> 20 kHz region) and an exponential increase with decreasing 
frequency at lower frequency (< 20 kHz region). A representative impedance spectrum measured 
at the end of the seeding period was compared to the series equivalent circuit model 1.3.3, 
regarding the impedance of the sensor before significant biofilm formation (Figure 2-5 (a)). Figure 
2-5 (b) depicts an experimentally determined impedance spectrum from the same device after 24 
hours of biofilm growth, compared to the model 1.3.3. This model includes the resistance of the 
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bulk solution (RSol), the resistance of biofilm formed on the surface (Rbio), the interfacial 
capacitance (Cdl), and the capacitance of the biofilm on the surface (Cbio). The empirically 
determined circuit parameters for each time point are shown in table 2.1. This confirms that an 
increase in capacitance associated with the biofilm helped drive the impedance decrease in the 
lower frequency range (< 10 kHz) that was seen in Figure 2-4. This is consistent with previous 
works showing that increased capacitance from adhered biofilm and increased double-layer 
capacitance arising from biofilm metabolism contributes to decreased impedance [15], [149]. This 
conclusion could be further evaluated experimentally by examining the impedance shift with 




Figure 2-4: 50 mV impedance spectra at different intervals throughout biofilm growth experiments, (a) 
without biofilm (control) and (b) with biofilm formation. The dotted boxes (expanded below) highlight the 
region from 20 Hz to 1 kHz to emphasize the differing responses. Relative percent change in impedance at 
5 representative frequencies (c) without biofilm (control) and (d) with biofilm formation. Control samples 
showed a uniform increase in impedance compared to a distinct frequency-dependent decrease in 




Figure 2-5: Theoretical models fit to match experimentally determined impedance spectra (a) before (t = 
0) and (b) after (t = 24 h) biofilm formation. The empirically determined circuit parameters for each fit are 
shown in table 2.1. 
Parameter t = 0 t = 24 
Rsol (Ω) 37.0 37.0 
Rbio (Ω) 0.5 4.0 
Cdl (µF) 18 18 
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Cbio (µF) 8 12 
Table 2-1: Circuit parameters for biofilm sensing impedance spectra. 
Furthermore, the real-time sensing capabilities of this flexible system were demonstrated, 
representing a significant advantage over present biofilm analysis techniques. To do so, the 
impedance at 100 Hz was tracked over the 24 hours growth period continuously to evaluate the 
real-time degree of biofilm formation. 100 Hz was selected as it showed highest sensitivity within 
the frequency range investigated, as shown in Figure 2-4 (d). The 100 Hz samples showed the 
largest change between the biofilm and the unseeded control in the impedance spectra. The 
percentage change in impedance over time, relative to the initial value, was calculated and 
compared for devices with and without biofilm formation. When bacteria were introduced into the 
device, biofilm formed on the surface and drove a decrease in the system impedance. The time-
lapse images in Figure 2-6 (a), along with their corresponding impedance sensor signals in Figure 
2-6 (b), indicate a correlation between this drop in impedance and the rapid expansion of the 
biofilm colony. The biofilm can be seen in the red boxes in Figure 2-6 (a), growing in a layer on 
the side of the catheter tube. The start of the growth phase at t = 0 ((i) in Figure 2-6) shows no 
biofilm and an impedance of 2.72 kΩ. An initial layer appears after 6 hours ((ii) in Figure 2-6), 
showing only a slight decrease in impedance relative to the impedance at t = 0. After 12 hours ((iii) 
in Figure 2-6) a thin layer of biofilm is visible, accompanied by a distinct drop in the impedance. 





Figure 2-6: (a) Time lapse images of platform in catheter tube, with the device in orange and the biofilm 
forming as a white streak along the edge of the tube in the red boxed region. (b) Impedance transient with 
lines indicating the impedance at each image. The initial spike in impedance is attributed to a small air 
pocket being flushed out of the tubing and then passing over part of the sensor [148]. © 2018 IEEE 
 
Figure 2-7: Average real-time impedance sensing results over the course of the 24-hour growth period, 
measured by the benchtop potentiostat. The blue triangles correspond to the control samples (without 
biofilm formation) and the red circles correspond to the samples with biofilm formation. The excitation 
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signal used was AC 50 mV at 100 Hz, chosen to optimize sensitivity. The error bars correspond to standard 
error (N = 5) [18]. 
The unseeded control, which has no bacteria to form a biofilm, showed a slight increase in 
impedance over the duration of the experiments (Figure 2-7). As described previously, this is 
attributed to the formation of small air bubbles on the sensor surface. Conversely, when bacteria 
are introduced into the tube, a biofilm forms, leading to a dramatic 30.3% decrease in the 
impedance (Figure 2-7) after 24 hours of growth. Similar to the above images, biofilm does not 
grow uniformly. On average, the impedance drops precipitously as the biofilm matures from the 
initial colonization to the rapid proliferation phase. The impedance decreases an average of 6.8% 
over the first three hours. However, there is a reduction in the rate of impedance decrease after this 
initial drop, as mature biofilms form and growth decelerates; from hour 3 to 24 the impedance 
decreases approximately 1% per hour. This result is consistent with the proliferation of biofilm 
after initial attachment (seeding phase), followed by a mature biofilm that may disperse bacteria 
throughout the system [150]. The shedding of planktonic cells could help contribute to the sensor 
signal plateauing by offsetting any continued growth [28], [29]. The lower rate of impedance 
decrease during the later portion of the growth phase could also be attributed to signal saturation, 
with additional biofilm growth beyond the range of the electrodes. 
The end-point biomass determined via CVS can be compared between samples with and 
without biofilm in this system after 48 hours, and the trend can be compared with the impedance 
sensing results. The biomass quantification results are shown in Figure 2-10 in the next section 
(2.2). The absorbance nearly doubled on average in samples with biofilm (sensing only) compared 
to the biofilm-free unseeded controls. The control signal represents the contribution from the LB 
media alone. The increased absorbance associated with biofilm was statistically significant 
according to one-way ANOVA (p < 0.05), confirming the increase in biomass. Furthermore, this 
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increase in biomass is correlated with the decrease in impedance, measured with the flexible 
sensor. This corroborates the suggestion that biofilm growth drives a decrease in impedance in 
real-time with this flexible device. 
2.2 Bioelectric Effect Treatment in a Cylindrical Environment Utilizing Flexible Sensor 
Electrodes 
In addition to biofilm detection during growth, I demonstrate removal of biofilm using the 
BE with this flexible device in a cylindrical environment, which reduces the concentration of 
antibiotics required for biofilm elimination. The BE is comprised of a low-intensity electric field 
combined with a low concentration of an antimicrobial compound to achieve synergistic biofilm 
removal. For this setup, the same electric field introduced for impedance sensing was utilized to 
administer BE treatment. This allows the flexible proof-of-concept device to significantly reduce 
the medical burden of the infection without excessive antibiotic use. Following 24 hours of growth, 
as described in the previous section, the BE treatment is administered on mature biofilms. The 
efficacy of this approach for biofilm removal is evaluated using end-point CVS biomass 
quantification. In addition, the impedance sensor capabilities can also be used to monitor the 
decrease in biofilm on the device surface in real-time. It is invaluable to develop approaches such 
as this to provide techniques for removing biofilms on devices, in addition to identifying them in 
real-time.  
2.2.1 Materials and methods 
The flexible device used in 2.1 was also used to administer the electric field needed for the 
BE. These tests were done using the same setup described in Figure 2-3, and the treatments were 
applied after the conclusion of the 24 hour growth period. Five samples were compared to evaluate 
sensing and BE efficacy: 1) Unseeded, 2) Sensing-only, 3) BE treatment, 4) Antibiotic-only, and 
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5) Untreated. The unseeded samples did not have any bacteria added and did have the 50 mV, 100 
Hz sensing signal. The Sensing-only sample was exposed to the 50 mV sensing signal over the 
duration of the experiment. BE treatment consisted of the sensing signal, with the gentamicin 
diluted in the LB media reservoir to a concentration of 10 µg/ml for the treatment phase. The 
Antibiotic-only samples did not have the impedance sensing voltage but did have 10 µg/ml 
gentamicin present during the 20-hour treatment period. An untreated control was seeded with 
bacteria but has neither the voltage associated with sensing nor the antibiotic. Only biomass 
quantification using CVS was performed for untreated samples; no impedance sensing was 
performed on these samples. The relative change in impedance was recorded as a percentage 
change relative to the initial impedance using (1). End-point CVS was performed at the end of the 
treatment period. The biofilm biomass following the completion of the growth phase was 
quantified using a CVS absorbance assay. CVS binds to the extracellular proteins and DNA 
associated with biofilm formation [151], [152]. CVS solution was prepared by adding 50 µg of 
CVS powder (Fisher Scientific) to 10 ml of deionized water. To perform the CVS assay, the 
catheter tube with the sensor was disconnected from the flow system, and one end was sealed with 
a 3-way stopcock. The tube was drained to remove media and non-adherent cells. The stopcock 
was sealed, and the tube was positioned vertically with the open end directed upward. The tube 
was then filled via pipette with 1 ml of the 0.0005% weight percentage CVS solution for 15 
minutes. The CVS solution was then drained from the tube, and both the tube and sensor were 
gently rinsed 4 times with 1x PBS to remove unbound CVS stain. Following this, the tube was 
filled with 1 ml of decomplexation solution (4:1 ethanol to acetone) for 30 minutes. CVS is soluble 
in the decomplexation solution, so the CVS bound to the biofilm dissolved in the solution and 
could be measured using OD. Finally, the solution in the tube was drained into a cuvette, and the 
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biomass was quantified via OD measurements at 590 nm using a UV (ultraviolet)-visible spectrum 
spectrophotometer (SpectraMAX). 590 nm was selected as the wavelength with the highest 
absorbance of crystal violet. One-way ANOVA was performed to evaluate the significance of the 
biomass quantification results. The impedance was recorded continuously, as described in 2.1, for 
real-time biofilm monitoring. The experimental conditions and timing are summarized in Figure 
2-8. 
 
Figure 2-8: Experimental conditions and timing showing when treatments were applied and when data was 
collected. Colored arrows correspond to EIS sweeps [148]. © 2018 IEEE 
2.2.2 Characterization of BE in a cylindrical environment 
Following the formation of a mature biofilm during the 24-hour growth period, the flexible 
electrode system was used to apply a BE-based treatment to achieve synergistic biofilm removal. 
This 50 mV signal maintained a similar electric field strength compared to our previous work 
where the BE was implemented successfully in a microfluidic device [16]. The combined real-
time impedance transients for both the growth and treatment periods are shown in Figure 2-9. The 
treatment portion of this plot was set to begin at 24 hours, with the subsequent change in absolute 
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impedance determined relative to the impedance at 24 hours and offset to the change in impedance 
for samples with or without biofilm during the growth period. The BE and (sensing-only) biofilm 
treatment transients start at the same point, as this is the average impedance for a 24 hour-old 
biofilm, which is then subjected to either the sensing signal or the sensing signal plus gentamicin 
(BE). The 50 mV signal alone (Sensing-Only, Biofilm) showed a 1% decrease in impedance during 
the treatment period relative to the impedance at the end of the 24-hour growth phase, indicative 
of negligible change in biofilm. However, when the synergistic BE treatment was applied, the 
sensor measured a 12% increase in impedance relative to the initial impedance of the mature 
biofilm at the start of the treatment phase/end of the growth phase. This suggests effective removal 
of the biofilm via the BE which has led to an increase in impedance because the film was no longer 
able to adhere strongly to the surface or accumulate ions after treatment. 
 
Figure 2-9: Growth (left): Percentage change in 50 mV impedance at 100 Hz for biofilm (sensing-only, 
red) and unseeded (blue) samples over a 24 hours growth period showing an initial drop followed by slowed 
growth. The large standard error indicates the high inherent variability of biofilm formation (N = 5). 
Treatment (right): Percent change in 50 mV 100 Hz impedance over the course of a 20-hour treatment 
period on a mature biofilm (i.e. relative to the impedance at the end of the growth phase). Removal of 
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biofilm via the BE led to a 12% increase in impedance compared with the 1% decrease for the sensing-only 
samples (N = 3) [148]. © 2018 IEEE 
A CVS absorbance assay was performed to quantify the amount of strongly adhered 
biofilm material on the surface of the tube following the treatment period (Figure 2-10). The 
untreated control, without the sensing signal or antibiotics, presented an average absorbance of 
0.385±0.106. This decreased to 0.159±0.021 for the BE treatment group, similar to the 
0.143±0.023 absorbance found with the unseeded control. The absorbance for the untreated control 
is attributed to the adsorption of macromolecules from the LB media onto the surface. The 
antibiotic-only group showed an absorbance of 0.377±0.028, while the sensing-only group had an 
absorbance of 0.263±0.036. The small decrease for the sensing-only group suggests that the 
electric field may contribute in reducing biofilm slightly. BE treatment yielded a significant 
decrease in biomass compared to the antibiotic-only sample (ANOVA p < 0.05). This data also 
indicates a distinct trend, showing the decrease in biomass from untreated or sensing-only samples 
to BE treatment (ANOVA p = 0.1054 and p = 0.0663, respectively). The unseeded control 
absorbance corresponded to the signal attributed to the presence of pure LB media. The similar 
absorbance after 24 hours of BE treatment indicated there was a negligible amount of adhered 
biomass remaining in the tube. The unseeded samples displayed significantly less biomass when 
compared with the sensing-only (p = 0.04693), antibiotic-only (p = 0.00287), or untreated (p = 
0.08976) groups. There appeared to be less biomass than the controls with the electric field or 
antibiotic alone, highlighting the synergistic effect of the treatment. Previous work suggests that 
the electrical energy of the sensing signal allows either an increase in the permeability of the 
bacterial cell membrane, enhanced diffusion of the charged antibiotic, or both [153]. This serves 
to explain the increased efficacy of antibiotics in reducing biofilm in the presence of the electric 




Figure 2-10: CVS to evaluate the biomass at the end of each of the five treatments, showing the decrease 
in biofilm due to the BE: Unseeded, Sensing-Only, Antibiotic (Anti)-Only, and Untreated, and the BE. 
(N=3) [148]. © 2018 IEEE 
2.3 Impact of Curvature on Device Performance 
An important factor to consider when adapting these devices from planar to cylindrical 
domains is how the sensing and treatment performance changes. The curved conformation of the 
electrodes can alter the electric field distribution and change the device functionality. I compare 
an electrode pair conformed in a catheter-scale cylinder to electrodes in a planar arrangement using 
a commercial FEA software. This approach allows a detailed study of sensitivity and saturation 
with regard to increasing biofilm thickness in each case. In addition to these simulations, I perform 
experiments conforming the flexible sensors designed in 2.1 to varying degrees of curvature 
relevant to biofilm formation. Performing biofilm detection and BE treatment experiments using 




2.3.1 Materials and methods 
2.3.1.1 FEA simulations 
I utilized COMSOL Multiphysics 5.2 commercial FEA modeling software to create 
catheter-scale models of a single pair of electrodes in two different conformations, cylindrical and 
planar. The cylindrical model consisted of a 4.5 mm diameter and 2 mm long cylinder, with 
electrodes defined on the cylinder surface. The electrodes were defined on one side of a rectangular 
model for the planar conformation. The width of the rectangular model is the same as the 
circumference of the cylindrical model (14.1 mm), with the depth the same as the radius of the 
cylinder (2.25 mm), and the length 2 mm. The gold electrodes in each model had an arc length of 
10 mm and a varying width of either 100 µm, 300 µm, or 500 µm. The spacing between the pair 
was also 100 µm, 300 µm, or 500 µm, respectively. These models are depicted in the results in 
Figure 2-14. From the outer surface of the cylinder to a depth varying from 0 to 0.5 mm, a layer 
of biofilm was defined. Biofilm was defined as a 10% dispersion of Escherichia coli cells in ECM 
via Maxwell’s mixture theory [154], [155]. The apparent permittivity and conductivity of biofilm 
was determined using the permittivity and conductivity of ECM, cell membranes, and cytoplasm 
[156]–[158]. The remaining volume of the cylinder was defined with the electrical conductivity 
and permittivity of LB media [159]. This model for defining biofilm electrically was developed 
by Subramanian et al [16]. The 3D electrodynamic simulation determined the current density 
throughout the system based on an applied AC potential (50 mV, 100 Hz), which was used to 
determine the impedance based on the current across a probe surface separating the two electrodes. 
The surface area of the probe allowed the current to be determined, from which the impedance (Z) 
was calculated based on equation 2.2, where I is the complex current from the simulation and V is 
the applied voltage.  
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𝑍 = 𝑉/𝐼       (2.2)     
The absolute impedance was determined as the magnitude of the complex impedance from 
equation 2.2 for each electrode width and spacing for biofilm thickness from 0 to 0.5 mm in 0.1 
mm increments. These models allow the impact of conformation and electrode spacing on 
sensitivity to increasing biofilm thickness to be investigated through the relative change in absolute 
impedance. The absolute impedance is the same metric generated by the device in 2.1. 
2.3.1.2 Variable curvature flow system 
To test the impact of curvature on device performance, the sensors were conformed at 
specified curvatures and incorporated into flow systems. The flexible sensors were fabricated as 
described in section 2.1. The fabrication process for conforming the sensors at specific curvatures 
is shown in Figure 2-11. The device was conformed around a 3D-printed mold (Formlabs Form 2, 
clear resin) with the desired curvature and taped to a glass microscope slide. PDMS (10:1 
base:curing agent, Dow Corning) was poured onto the molded device and cured for 3 hours at 60 
°C to maintain the sensor at the specified shape. Three different molds were used: rcurvature = 12.7 
mm (curvature comparable to a 1 in pipe), rcurvature = 2.25 mm (comparable to a 18 Fr intermittent 
catheter), and a planar control. The cross-sectional area of the molds was kept constant to ensure 
that the shear force was the same for each experiment. The mold was then removed and tygon 
tubing was added at the inlet and outlet to interface the curved electrodes with the flow system. 
Epoxy was used to seal the interface between the tygon tubing and molded device. The flexible 
sensor leads and contact pads extend beyond the PDMS-molded area and were exposed so that 
they can be interfaced with the potentiostat. Representative devices conformed in each of the three 




Figure 2-11: Fabrication process for microfluidic device with electrodes in a cylindrical conformation. (1) 
Polyimide film with sensor conformed around mold on glass. (2) PDMS was poured over sensor and mold. 
(3) Mold was removed, leaving the sensor in the appropriate curvature [160].  
 
Figure 2-12: Flexible device conformed in (a) 1” water pipe configuration, (b) 18 Fr catheter curvature, 
and (c) planar configuration. Red outline delineates the fluidic channel with the same cross-sectional area 
around which the device is conformed. Scale bar 1 mm [160]. 
A flow system similar to the one used to evaluate the proof-of-concept device was used for 
examining the impact of curvature on device performance (Figure 2-13). A media reservoir was 
filled with 500 ml of LB media and interfaced with the curved device platform using tygon tubing. 
A peristaltic pump (Cole Parmer) was used to drive the flow. Tygon tubing from the outlet of the 
curved device platform connects to a waste flask. The curved device was contained within an 




Figure 2-13: Experimental setup for growing and treating biofilm on curved device [160]. 
Escherichia coli were prepared to a concentration of OD600nm = 0.25 in LB media as 
described in section 2.1.1. 1 ml of this preparation was introduced via the inlet tubing to the curved 
device and allowed to adhere for 2 hours (seeding). Seeding was followed by 24 hours of LB media 
flow at 3.5 ml/h (growth). Throughout the growth period, the impedance was recorded at 100 Hz 
(50 mV) using a potentiostat (Model 660D, CHInstruments) similar to the procedure described in 
section 2.1.1. After the conclusion of the growth period, gentamicin (Sigma) was added to the 
media reservoir to a concentration of 10 µg/ml and flow was continued for 24 hours (treatment). 
The antibiotic and sensor signal comprise the BE. Impedance spectra at 50 mV from 10-2000 Hz 
were recorded at the start of the treatment period and after 24 hours of exposure to the BE. This 
frequency range was selected based on the results from Figure 2-4 to be the most sensitive to 




2.3.2 Sensor curvature modeling 
 
Figure 2-14: COMSOL electrodynamic simulations of electrodes with biofilm showing the resulting 
current density in (a) an 18 Fr catheter configuration and (b) in a planar configuration [160], [161]. 
The electrodynamic COMSOL simulations yielded the current density between two 
electrodes in a catheter-scale planar and curved domain. Representative 3D heat maps for each of 
these setups is depicted in Figure 2-14. These models clearly depict that the majority of the current 
is concentrated near the electrode surface. The measured impedance values in between the two 
electrodes were calculated based on the current density and applied voltage (50 mV), and the 
change in impedance with increasing biofilm thickness was determined. The relative change in 
impedance is shown in Figure 2-15. In each setting, the sensor response followed a similar pattern. 
The impedance increased with increasing biofilm thickness, approaching a 30% increase. The 
smallest electrode separation showed the largest change but also appeared to saturate quickly, 
showing little change after 0.2 mm of biofilm. By comparison, the widest electrode separation 
showed the smallest increase but did not appear to saturate at the higher thickness values. The 300 
µm width/spacing proved to be an intermediate dimension, showing decreased saturation 
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compared to the 100 µm width/spacing and increased sensitivity compared to the 500 µm 
width/spacing. Notably, both the pattern and magnitude of the impedance change were very similar 
between the planar and cylindrical conformations. I attribute this to the fact that the radius of 
curvature is relatively large compared to the dimension of the electrodes and the resulting electric 
field distribution. The penetration depth of the electric field is expected to be comparable to the 
spacing of the electrodes [96]. In terms of sensor performance, this geometry appears effectively 
planar. 
 
Figure 2-15: Current density yields relative change in impedance at 100 Hz as biofilm thickness increases 
above the electrode for the (a) cylindrical and (b) planar models [160], [161]. 
There are some notable weaknesses with this electrodynamic model for biofilm sensing. 
The impedance appeared to increase, directly contradicting the experimental results from section 
2.2 indicating that a decrease in impedance is associated with biofilm growth. There are a number 
of factors contributing to this discrepancy. For one, this model only uses a single pair of parallel 
electrodes, as opposed to the IDE arrangement in the experiments. While this may impact the 
magnitude of the results, I would not expect this to produce the opposite trend. It is also important 
to note that biofilm is a highly complex material, and it does not grow in uniform layers. I would 
also not expect this to produce opposite results. Most importantly, this simulation models each 
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area as if it were a block of material with set dielectric properties. However, in reality these 
impedance sensors are electrochemical sensors that are responsive to the ions and molecules that 
are free to move and interact with the electrodes [162]. The LB media in the experimental setting 
contains numerous bacteria, while the simulation models the bulk solution as pure LB media with 
constant dielectric properties. In addition to the specified electrical properties of the cells and 
matrix, biofilm growth on the sensor surface is also associated with many charged molecules and 
metabolites that can impact the sensor [15]. Furthermore, the properties of biofilm and bacteria are 
dynamic, changing over time in different stages of development [109]. Regardless, this simulation 
still suggests that the cylindrical geometry does not significantly alter the current distribution. 
Thus, this simulation still supports the conclusion that cylindrical catheter-scale geometry does not 
impact biofilm sensor performance. 
2.3.3 Experimental sensor curvature evaluation 
Each of the three curvatures displayed a similar pattern during the growth period. The 
impedance decreased approximately 15% rapidly over the first 5 hours after the seeding period. 
The rate of decrease then slowed until it appeared to plateau. Based on the known characteristics 
of biofilm growth, this pattern seems to correspond to the rapid proliferation of bacteria and 
biofilm, followed by a mature biofilm phase [37], [109]. Importantly, the average relative 100 Hz 
impedance changes for the rcurvature = 2.25 mm, rcurvature = 12.7 mm, or the planar control at the end 
of the 24-hour growth period were not significantly different (p > 0.05). These impedance 




Figure 2-16: Temporal impedance response at 100 Hz showing similar decreases in impedance during the 
24-hour growth phase, followed by similar increases in impedance during the subsequent treatment phase 
for 18 Fr curvature (blue), planar (green), and 1” pipe curvature (red). The error bars correspond to standard 
error (N = 3). Dashed lines correspond to when impedance spectra (Figure 2-17) were gathered following 
biofilm growth (red) and treatment (blue) [160]. 
The BE was also administered using this system, and the real-time relative impedance 
change was examined. In each case, the average impedance change increased steadily throughout 
the treatment period, suggesting that there was a biofilm removal effect with the application of the 
electric field and 10 µg/ml gentamicin. Likewise, the average change in impedance was not shown 
to be significantly different at the end of this period (p > 0.05). It is expected that the BE would 
function similarly since the electric field distribution did not appear to be altered dramatically 
between the planar and curved conformations. EIS at the beginning and end of the treatment 
periods shows a comparable increase in impedance following BE application for each of the 




Figure 2-17: 10 Hz - 2 kHz impedance spectra at 50 mV for (a) 18 Fr catheter curvature, (b) 1” pipe 
curvature, and (c) planar control. The red corresponds to the impedance after the growth of a biofilm and 
the blue corresponds to the impedance after 24 hours of treatment. Each sample displays similar 
characteristics, increasing at low frequencies (N = 3 measurements on a single sample) [160]. 
59 
 
In total, it appears that curvature at this scale produces no significant differences in flexible 
device functionality for both impedimetric detection and BE treatment. At this scale the electric 
field is concentrated at the surface, with similar current distributions in the planar and curved 
conformations. This similarity was identified using COMSOL commercial modelling software and 
confirmed experimentally with regard to both aspects of the device. This conclusion is significant, 
as it supports the use of this system in catheters, as well as other domains with complex surface 
geometry at this size scale. 
2.4 Synopsis/Summary 
In this chapter, I have presented a strategy for fabricating flexible electrodes to adapt LOC 
biofilm sensing and treatment systems for use in cylindrical domains where biofilms can lead 
infections, such as urinary catheters. I utilized this proof-of-concept device in a catheter-scale 
cylindrical conformation and demonstrated the capacity for real-time monitoring of biofilm growth 
via impedance sensing. This is the first step towards implementing novel microsystems approaches 
in CAUTI applications. I was also able to show that the same device could be used to apply the 
BE for biofilm elimination with reduced antibiotic use. The efficacy of this treatment in the 
cylindrical domain was supported by biomass staining and real-time impedance sensing. These 
key functions form the basis of the integrated sensing and treatment system for CAUTI 
management throughout the remainder of this thesis. I was also able to explore the impact that the 
cylindrical conformation may have on device performance. Both the commercial modelling 
software and experiments with precisely conformed sensors suggested that the device performance 
does not change notably in a cylindrical arrangement at the catheter size scale. This supports the 
use of this device for urinary catheter applications, but also other domains with non-planar 
geometry at this scale in the future.  
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Chapter 3: Foley Catheter-Integrated System 
The proof-of-concept device developed in the previous chapter represents a potentially 
meaningful approach for addressing the challenges associated with biofilm formation. In order to 
realize the potential of this device for reducing CAUTI, it must be seamlessly integrated with 
existing catheters in a way that does not interfere with standard urinary catheter operation, 
including urine drainage and balloon anchoring. Furthermore, to achieve successful integration 
with current medical practices, this system must demonstrate biocompatibility with human tissue 
and allow users to adjust monitoring and treatment parameters in a user-friendly manner. 
In this chapter, I explore two disparate electrode integration strategies. The first involves 
containing the flexible proof-of-concept impedance sensor, described in Chapter 2, within a 3D-
printed insert, which can then be directly interfaced with the catheter. To further verify the viability 
of this approach for catheter integration, I examined the biocompatibility of the materials required. 
As an alternative strategy, electrodes were electroplated directly on the catheter surface. Finally, I 
describe the development and implementation of the microelectronics and mobile application 
needed for system control for CAUTI management. The results from this chapter comprise an 
integrated system with both sensing and treatment capabilities, as described in the previous 
chapter, incorporated with a commercially available Foley catheter. 
I am very grateful for the help of Dr. Sangwook Chu with regard to the design and 
fabrication of the insert and the process flow for the in situ electrodes. Ashley Chapin provided 
support for the biocompatibility experiments. Dr. Luke Beardslee and Justin Stine provided 




3.1 3D-Printed Insert for Flexible Electrode Integration 
This approach relies on a 3D-printed device-insert module to integrate the electrodes with 
a commercially available Foley catheter, depicted in Figure 3-1. The device-insert module is 
comprised of two channels that match the dual channels of the Foley catheter (Figure 3-1 (a)). The 
main channel mimics the dimensions of the urine drainage channel and houses the flexible device. 
The second channel is a groove that can contain a steel tube for the anchoring balloon inflation 
channel (Figure 3-1 (b)-(c)). In this manner, the device-insert module allows the essential functions 
of the urinary catheter to be maintained while adding the functionality of the flexible sensing and 
treatment electrodes. A transverse cut can be made in the catheter at any point along the main 
catheter body, and the insert module can be interfaced with each cut end, ensuring continuity for 
both channels. 
 
Figure 3-1: (a) Foley catheter cross section showing the urine drainage and balloon anchoring channels. 
(b) Cross section of insert showing channels corresponding to the two channels of the urinary catheter. (c) 
Schematic of insert module for housing the flexible device with barbed connectors for leak-free interfacing 
with a Foley catheter. 
In this section, I introduce this integration approach in detail, confirming that each of the 
essential functionalities of the catheter are maintained after inserting the module. I also confirm 
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that the materials used are biocompatible per an ISO-10993-5 standard biocompatibility assay 
[163]. 
3.1.1 Materials and methods 
3.1.1.1 Insert fabrication and integration 
The device-insert module was 3D-printed using a Form 2 sterolithography (SLA) 3D 
printer (FormLabs) using standard clear resin [164]. As shown in Figure 3-2 (a), barb structures at 
the insert tips allowed a robust leak-free connection with the 22 Fr Foley catheter (Bard) urine 
channels, and a longitudinal groove along the outside wall accommodated a stainless-steel tube 
(McMaster-Carr) to connect the saline channel for balloon inflation. The flexible electrodes (20 
nm Cr/200 nm Au) were fabricated on polyimide substrates (24 µm thick) via a standard electrode 
patterning microfabrication technique (lift-off, described in chapter 2), and the overall device 
footprint (48 mm x 10 mm) was adjusted via optical mask design (Figure 6-2 in Appendix A) to 
conform onto the inner lumen of the insert module without any overlap. Prior to being rolled into 
the module, electrical contact leads were established with 36-gauge wires (Calmont Wire and 
Cable, Inc) and copper tape (McMaster-Carr), followed by insulation with polyimide tape 
(McMaster-Carr). The wires ran along the inside of the catheter until exiting near the connection 
for the urine bag and were connected to the PCB. 
The key catheter functions, urine drainage and balloon anchoring, were verified with the 
device-insert module integrated with the catheter and inserted into a 3D-printed silicone bladder 
model (Lazarus 3D). The bladder was filled with deionized (DI) water and drained continuously 
at a rate of 2.5 ml/min. The drainage function was confirmed as water was drained from the bladder 
via the insert-modified catheter for 4 hours. An additional bladder model customized to be printed 
with translucent silicone (Lazarus 3D) was used to confirm the balloon anchoring function. The 
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balloon was inflated after insertion with 1x phosphate-buffered saline solution with blue food dye 
for visualization. 
3.1.1.2 Insert biocompatibility evaluation 
Material cytotoxicity testing was performed following the ISO 10993-5 protocol [163]. 
This assay involved incubating materials with growth media for a set period. Cells were then 
exposed to the media to determine the impact of any potentially cytotoxic compounds that leached 
into the media. The cytotoxicity of two 3D-printable potential insert materials was examined: 
standard clear resin (Formlabs, Form 2) and MED610 (Stratasys, Objet500 Connex 3) [164], [165]. 
These materials were selected because they can be printed with sufficient resolution to generate 
the insert features reliably. In addition, the MED610 is claimed to be biocompatible by the 
manufacturer [165]. The silicone catheter material served as a non-toxic negative control. 0.06% 
hydrogen peroxide served as the positive control, inducing a cytotoxic response [166]. Blank 
samples without any material were also tested. 
Caco2 epithelial cells (ATCC: HTB-37) were seeded onto sterile glass coverslips and 
grown to sub-confluency at 37 °C under 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM) 
with 10% Fetal Bovine Serum (FBS) in a standard 24-well cell culture plate (BD). Material 
samples were prepared using a modified washing/rinsing protocol described by Ngan et al. [167]. 
Any support material remaining on the MED610 after 3D-printing was removed using a 2% 
sodium hydroxide and 1% sodium sulfite solution, which was then neutralized using 5% acetic 
acid for one minute. Subsequently, samples from both printers were soaked in DI water for one 
minute then sonicated in isopropyl alcohol followed by DI water for 2 hours. Finally, the samples 




The cleaned samples were immersed in DMEM with 10% FBS at 37 °C for 24 hours. This 
temperature corresponds to average body temperature, and the duration of immersion corresponds 
to a catheter that was indwelling for one day. These conditions help to ensure that the 
biocompatibility assay results were relevant for indwelling catheters. The samples were then 
removed, and the remaining solution was referred to as the extract, containing the variety of 
compounds that may have leached out of the 3D-printed material into the surrounding media. The 
extract was then introduced to the sub-confluent culture and incubated at 37 °C for 24 hours. The 
cells were imaged using bright field optical microscopy (Olympus, CKX53) before and after 
exposure to the extract. After exposure and bright field imaging, the cells are fixed in 4% 
paraformaldehyde. This was done by removing the media, gently rinsing with tris buffer, and 
immersing with paraformaldehyde for 10 minutes in each well. Then, the wells were stained for 
viability using LIVE/DEAD stain (Thermo Fisher Scientific) and imaged using a confocal 
microscope (LSM 700, Zeiss). The LIVE/DEAD stain consisted of 1.5 µl/ml each of propidium 
iodide and syto-9 in tris buffer. The stain was incubated in each well for 15 minutes. The samples 
were then mounted onto glass slides after being rinsed with tris buffer. Each type of sample was 
done in triplicate.  
3.1.2 Foley catheter integration 
A Foley catheter was integrated with the device insert module, as depicted in Figure 3-2 
(b). The modular assembly of the flexible IDEs and 3D-printed insert allows facile integration at 
a sliced interface of the commercial urinary Foley catheter via two flow channels - saline and urine 
channels. The insert module is integrated near the distal tip close to the balloon with the sensor on 
the inner lumen, as this is the area most commonly colonized by biofilm [168]. A major design 
consideration was to maintain the standard urinary Foley catheter configuration when integrating 
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the insert module and associated electronics. This was to assure that the primary functions of the 
urinary catheter (urine drainage, bladder anchoring by inflating the balloon at the tip) would be 
sustained. The system displayed appropriate liquid drainage from the bladder through the normally 
inserted catheter without any leakage, draining water at a rate of 2.5 ml/min over four hours (Figure 
3-3). In addition, this system enabled inflation of the anchoring balloon, demonstrating that the 
intended function of the catheter is maintained (Figure 3-4). This approach allows not only 
unimpeded functionality of the Foley catheter but will also enable biofilm management via the 
integrated flexible device. 
 
Figure 3-2: (a) Components comprising integrated system including steel tube for saline balloon inflation 
channel, 36 AWG wires to connect PCB with embedded sensor, flexible IDEs, and 3D-printed insert 
module with barbed connectors for leak proof connection with urine drainage channel. (b) Optical image 




Figure 3-3: System inserted into silicone bladder with water flowed continuously over 4 hours at 2.5 
ml/min. Optical images confirm no leakage from the insertion interface [169]. 
 
Figure 3-4: Optical image of device inserted into translucent silicone bladder, showing the anchoring 
balloon inflated with phosphate buffered saline solution colored with blue food coloring [169]. 
3.1.3 Biocompatibility testing 
It is very important to establish that this approach is not harmful towards the host when 
inserted. This is a key concern of regulatory agencies such as the US Food and Drug 
Administration. Towards this end, I evaluated the cytotoxicity of the potential materials for the 
Foley catheter insert using a protocol based upon the ISO10993-5 standard for evaluating material 
cytotoxicity [163]. Representative bright field images of the cells at subconfluency immediately 
before the addition of the material extract and after 24 hours of exposure to each of the material 
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extracts are shown in Figure 3-5. In each case, the cell morphology does not show a noticeable 
change. The exception is the positive control containing hydrogen peroxide; these cells are small 
with rounded morphology indicative of cell damage [170]. This result is further examined by the 
LIVE/DEAD stain images showing healthy cells with propidium iodide concentrated on the outer 
membranes and syto-9 concentrated within the cells at the nucleus (Figure 3-6). This stain indicates 
healthy membrane integrity, in addition to cell morphology. Again, the positive control is an 
exception, showing poor morphology with propidium iodide penetrating the intracellular space 
due to poor membrane integrity. Notably, MED610 also showed poor morphology with the 
LIVE/DEAD stain. This could be indicative of some harmful compound being released, such as 
MED610 support material. This support material is potentially toxic, and it has been shown that 





Figure 3-5: Brightfield images of representative samples before (left) and after (right) exposure to material 
extracts: (a) blank sample, (b) hydrogen peroxide (positive control), (c) silicone catheter (negative control), 
(d) clear resin, and (e) MED610. Scale bar corresponds to 50 µm. 
 
Figure 3-6: Representative LIVE/DEAD stain images after exposure to material extracts and fixing with 
formaldehyde: (a) blank sample, (b) positive control (hydrogen peroxide), (c) negative control (silicone 
69 
 
catheter), (d) clear resin, and (e) MED610. Contrast was decreased 20% and brightness was increased 40%. 
Scale bar corresponds to 50 µm. 
This analysis suggests that there are not harmful leachates in the clear resin that will 
damage human cells. It is also important to note that the standard clear resin does not have a 
secondary support material that may be toxic and easily leached into the surrounding environment, 
as seen with MED610. Improving the washing protocol to better remove this material could 
improve the biocompatibility of MED610. This analysis only examined one aspect of 
biocompatibility – the material leached from the device into the environment. These potentially 
harmful leachates are important when evaluating cytotoxicity of indwelling devices [167]. 
However, this analysis did not include direct contact between the materials and the cells, as occurs 
when a catheter is inserted. Furthermore, testing should be performed utilizing a more realistic 
medium, such as artificial urine. These experiments would help further establish the viability of 
these materials for an integrated catheter system. 
3.2 In situ Fabrication of Urinary Catheter Electrodes 
The insertion process for integrating flexible electrodes can present limitations as the 
rolling/deforming of the brittle thin-film metal electrodes can lead to unwanted fractures and poor 
electrical contact [171], [172]. Furthermore, electrode-based transducers fabricated on non-
stretchable polymeric substrates do not conform well to more complex surfaces [173]. In this 
section, I overcome this potential challenge by incorporating direct plating of the electrodes onto 
the catheter surface, with 3D-printed templates serving to selectively screen the catheter surface. 
This process does not rely on cumbersome fabrication technologies such as photolithography and 
physical vapor deposition. Instead, an aqueous electroless plating process is carried out directly on 
the inner lumen of the catheter with the 3D-printed mold, and a subsequent electroplating process 
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completes the electrode patterning. Electroless deposition of nickel yields a conformal metal 
coating via immersion in a plating bath, and this layer acts as a conductive seed layer for gold 
electroplating [174], [175]. I demonstrate electrode fabrication and biofilm sensing directly on the 
cylindrical polymeric surface of the catheter. Given the multitude of medical devices with similarly 
complex polymeric surfaces that would benefit from integrated sensors, this technique has the 
potential to be readily applied for a wide range of applications. 
3.2.1 Materials and methods 
The gold impedance sensor electrodes were fabricated directly on a 22 Fr elastomeric Foley 
catheter (Bard) using the process depicted in Figure 3-7. (i) The catheter was initially coated in a 
25 µm-thick layer of parylene-C (Specialty Coating Systems, Labcoter 2) to reduce the mechanical 
mismatch between the plated metal and the silicone polymer substrate and improve adhesion. 
Cracks appeared in the metal without this initial parylene-C layer, resulting in a significant loss of 
conductivity. (ii) The samples were then cleaned using acetone, methanol, and isopropanol to be 
prepared for the following Ni electroless plating step. Oxygen plasma treatment (200 W, 1 min) 
(Branson, Barrel Photoresist Stripper) introduced reactive carboxylic groups to the surface of the 
parylene-C to improve the adhesion of the electrodes. Immediately after oxygen plasma treatment, 
the catheters were immersed in 0.026 M stannous chloride solution in 1:1 methanol and water with 
0.07 M trichloroacetic acid for 45 minutes. This sensitization step bonded tin ions to the surface. 
After rinsing with methanol, a 3D-printed mold was inserted into the catheter, screening portions 
of the inner lumen from the electroless plating solutions and producing separate electrodes. 3D 
printing dramatically simplified the electrode patterning compared to techniques like 
photolithography, particularly in hard to reach areas like the catheter lumen. The mold was printed 
using a FormLabs Form 2 SLA 3D printer with clear resin. After the mold was added, the catheter 
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was filled with a 10 mM sodium tetrachloropalladate solution for 5 hours, which replaces the tin 
on the surface with palladium. Palladium served as a nucleation site for the formation of the nickel 
seed layer for the following gold electroplating step. Immersion for 45 seconds in a nickel 
electroless plating bath generated a thin nickel layer (<50 nm) on the catheter inner lumen. (iii) 
The 3D-printed mold was removed for the Au electroplating. The device was immersed in TSG-
250 (Transene) commercial electroplating solution and cycled from 0 to -0.5 V for 100 cycles at a 
scan rate of 25 mV/s using a VSP-300 potentiostat (Biologic). (iv) The resulting electrodes were 
then coated with a 1-µm thick layer of parylene-C to prevent metal ions from leaching into the 
environment. SEM and energy dispersive spectroscopy (EDS) analysis were used to examine the 




Figure 3-7: Foley catheter and the process flow depicting the in situ sensor electrode patterning on the 
inner lumen of a urinary catheter for biofilm detection [176]. © 2019 IEEE 
As depicted in Figure 3-8, the catheter sections with plated electrodes were interfaced with 
tygon tubing (Cole Parmer) to form a flow system for introducing fresh LB growth media (Sigma) 
and bacterial cells. Electrical connections were made using 24-gauge wire clipped to each of the 
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two electrodes. The electrical connections and tubing were sealed using epoxy. A peristaltic pump 
(Cole Parmer) was used to drive flow at 7 ml/h through the system from an LB media reservoir 
through the catheter with the sensor to a waste reservoir. The media and waste reservoirs were 
sterilized in an autoclave at 121 °C. The catheter and tubing were sterilized by flushing with 
ethanol and UV light exposure for an hour. The entire system was assembled in a sterile biosafety 
cabinet. 
  
Figure 3-8: Experimental setup comprised of the catheter device interfaced with media and waste reservoirs 
via tygon tubing for delivering fresh media during biofilm growth experiments. Scale bar 5 mm [176]. © 
2019 IEEE 
Escherichia coli K12 W3110 were cultured overnight in a 5 ml culture tube in an incubator 
shaker (Brunswick Scientific) at 250 rpm and 37 °C. The bacterial culture was diluted to an OD600 
nm of 0.25 and added to the system via syringe. The bacteria were allowed to attach for 2 hours to 
the sensor surface under a no-flow condition. Then, LB media was flowed for 24 hours as the 
biofilm grew. No bacterial cells were added in the control samples. Impedance spectra were 
gathered using a potentiostat (CHInstruments) from 10-106 Hz at a 50 mV amplitude. These 
spectra were gathered before the introduction of bacteria with LB media only, at the beginning of 
the 24-hour biofilm growth period, at the end of the biofilm growth period, and after the growth 
period after cleaning with ethanol. This last measurement with LB examined the electrode 
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integrity. In addition, the impedance was monitored in real-time at 100 Hz throughout the growth 
period.  
3.2.2 Electrode materials characterization 
The sensor electrodes patterned on the inner lumen of the catheter are shown in the cross-
section image of the catheter section in Figure 3-9 (a), demonstrating the viability of this approach 
for patterning electrodes for sensing on a catheter. The pattern used in this case was a rectangular 
mold with rounded edges (Figure 3-9 (b)) to screen the inner catheter lumen for selective 
electroless plating. More complex electrodes with larger sensor interfaces could be produced using 
more complex 3D printed molds, such as interdigitated patterns. Figure 3-9 (c) i-iii shows cross-
section SEM images from the electrode-patterned catheter with corresponding EDS scans. The 
silicone, metal, and the two parylene-C layers are shown distinctly on the surface. EDS analysis 
(Figure 3-9 (c-d)) confirms each of these layers by means of their signature elements, gold at 2.120 
keV (electrodes), chlorine at 2.622 keV (parylene-C), and silicon at 1.749 keV (silicone catheter). 
The key difference between the screened (Figure 3-9 (c) i) and the exposed (Figure 3-9 (c) ii) areas 
is the lack of a metal layer. The well-defined electrode pattern edge (Figure 3-9 (c) iii) clearly 
indicates the success in use of the 3D-printed screening mold for patterning of in situ electroless 




Figure 3-9: (a) Cross-sectional optical image of the in situ electrode patterned Foley-catheter. (b) Optical 
image of the 3D-printed mold for selective screening of electroless plating process, which appears black 
due to the nickel layer. (c) SEM characterization corresponding to areas (i-iii) in (a) of layer formation with 
EDS scans from gold, chlorine, and silicon, which are the signature elements for the electrodes, parylene-
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C, and the catheter, respectively (scale bar: 20 μm unless specified). (d) A comparison EDS spectrum 
acquired from catheter sections screened by the screening mold (black) and exposed to Ni electroless plating 
(red), confirming selective pattering of gold electrodes [176]. © 2019 IEEE 
3.2.3 Plated electrode biofilm sensing 
Impedance spectroscopy at the beginning and after 24-hours of biofilm growth displayed 
a frequency-dependent decrease in impedance associated with biofilm growth (Figure 3-10 (a)). 
This is consistent with previous reports and the results from Chapter 2, indicating that the 
capacitive component of the impedance changes with biofilm formation due to the accumulation 
of charged proteins and metabolites, leading to a decrease in capacitance [15], [148], [149]. In 
contrast, control samples without any biofilm showed a frequency-independent increase in 
impedance (Figure 3-10 (b)). We suggest that this is related to electrode degradation, potentially 
caused by the dissolution of metal ions due to the applied voltage in an electrolyte media containing 
chloride ions [177]. This is further evidenced by impedance spectroscopy of the sensor electrodes, 
which had been used to detect biofilm before the cells were added and after cleaning with ethanol. 
The electrodes displayed a frequency-independent increase in impedance when measuring the 
impedance in LB media after the electrodes had been cleaned of biofilm (Figure 3-10 (c)). A 
similar trend is seen in the control electrodes before and after the growth period (Figure 3-10 (d)). 
The increase in impedance after the removal of biofilm with ethanol reinforces the role of biofilm 
in the decrease in impedance seen with the sensor. Overall, this suggests that this is a viable 




Figure 3-10: 50 mV impedance spectra with in situ fabricated electrodes (a-b) at the beginning of the 
biofilm growth period (blue) and at the end of 24 hours of biofilm growth (red). Samples with biofilm (a) 
showed a decrease in impedance, whereas control samples (b) without bacterial cells showed an increase 
in impedance (N = 3 measurements). (c-d) Electrodes in only LB media before and after use in biofilm 
sensing experiments for (c) biofilm sensing and (d) control samples (N = 3 measurements) [176]. © 2019 
IEEE 
The in situ patterned electrodes were further utilized for continuous, real-time monitoring 
of biofilm formation. This is an essential element of more effective biofilm infection management, 
allowing a continuous readout of the state of the device surface. 100 Hz was selected for biofilm 
monitoring, as it is in the middle of the frequency range, which displayed an impedance decrease 
(Figure 3-10 (a)) consistent with the results from Chapter 2. The impedance was recorded 
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continuously for samples with and without biofilm over 24 hours (Figure 3-11). The samples with 
biofilm showed a sharp decrease over the first 7 hours, followed by a plateau of relatively little 
change over the next 17 hours. In total, the impedance decreased approximately 10% over the 24-
hour period. This is consistent with the growth dynamics of bacterial biofilm, with a rapid growth 
phase followed by a stationary mature biofilm phase [109]. In contrast, the control sample without 
any bacterial cells showed an increase in impedance of approximately 20%. This increase was 
relatively steady throughout the 24-hour period. We suggest that this is due to the electrode 
degradation and the formation of small bubbles that arise due to thermal expansion when the media 
becomes warmer in the incubator after being stored at room temperature. 
These results were also compared to continuous biofilm impedance sensing results using 
the flexible impedance sensor conformed on a urinary catheter. This device was fabricated 
monolithically using photolithography, and then must be rolled and inserted into the catheter. Both 
the control and biofilm sensing samples displayed similar behavior to the in situ fabricated 
electrodes. Each of the biofilm samples showed a significant decrease in impedance, but the in situ 
fabricated electrodes saturated faster. This is not considered a problem as the initial onset of 
biofilm formation is most important for prompt infection detection. The larger overall decrease 





Figure 3-11: Impedance transients at 100 Hz showing real-time biofilm sensing results. The green and blue 
lines show the increasing impedance of control samples for the in situ fabricated device and flexible device, 
respectively. The magenta and red lines show the decreasing impedance for the biofilm samples of the in 
situ fabricated device and flexible device, respectively [176]. © 2019 IEEE 
We have introduced an innovative in situ fabrication strategy for producing sensor 
electrodes on inaccessible medical device surfaces, particularly on urinary catheters. The sensors 
show similar performance to externally fabricated biofilm impedance sensors without a 
complicating integration step. It should be noted that this approach was only demonstrated on 
sections of a urinary catheter. The patterning scaffold would need to be redesigned to robustly 
pattern a full-scale catheter. This sensor system has the potential to serve as an integral tool for 
biofilm infection management. This technique can be applied to additional medical device surfaces 
that are vulnerable to biofilm colonization, particularly polymeric surfaces with complex 
geometries. Furthermore, introducing more complex mold designs to increase the electrode 
interface can improve the performance of these devices. 
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3.3 Custom Electronics Development for Wireless Control of Sensing and Treatment 
In order to integrate this sensing and treatment approach most effectively with a urinary 
catheter, the electronics and control systems that accompany the flexible transducer also need to 
be integrated in a seamless and user-friendly manner. To achieve this goal, commercial off-the-
shelf (COTS) electronic components were utilized to miniaturize the sensing and treatment control 
system. This approach also enables wireless communication via Bluetooth, allowing patients and 
healthcare providers greater freedom while monitoring biofilm growth and administering 
treatment. Also, a custom mobile application was developed to facilitate the implementation of 
this system by researchers and clinicians who have no special expertise in utilizing this type of 
transducer. This application integrates both functionalities in a seamless way using a single 
interface. In this section, I describe the custom-developed electronic system and mobile application 
in detail. In addition, I confirm the viability of the COTS impedance converter used for biofilm 
monitoring. 
3.3.1 Biofilm management printed circuit board (PCB) 
The goal of the embedded system development was to incorporate the impedance sensing 
and BE treatment capability presented in previous sections with a user-friendly interface and 
control system, which can be seamlessly integrated with an indwelling catheter in either a hospital 
or ambulatory setting. The PCB can be adhered to the external portion of the catheter, connected 
via 36 AWG wires (McMaster), and reused. The key specifications for the circuit design include 
effective implementation of the sensing and treatment signals, small form factor, low power 
consumption, and the ability to transfer data wirelessly. Furthermore, the system was specifically 
designed to measure impedances on the order of 102 Ω, which was determined in previous sections.  
81 
 
The circuit for the biofilm management PCB, shown in Figure 3-12, contains three critical 
components: the BGM121 Bluetooth microcontroller unit (MCU), the AD5933 (Analog Devices) 
impedance sensing module, and the AD2S99 (Analog Devices) sinewave oscillator [178]–[180]. 
The BGM121 MCU is an ideal wireless Bluetooth Low Energy (BLE) solution (Silicon Labs), 
which contains several energy modes to conserve power, an integrated antenna for efficient radio 
frequency data transmission, necessary peripheral functions to obtain data, and a robust integrated 
development environment for MCU programming. This system allowed wireless control over 
switching between three major modes of operation: Sensing mode with the AD5933, Treatment 
mode via the AD2S99, as well as a Shutdown mode that consists of both ICs being switched off 
for efficient energy use. In Sensing mode, the AD5933 measures the 2 kHz impedance of the 
electrodes to determine the degree of bacterial growth. In Treatment mode, the AD2S99 generates 
a 20 kHz sine wave that has been shown to be capable of inducing the BE [153]. Electrical 
specifications for the BGM121, AD5933, and AD2S99 are summarized in Table 3-1. 
Power State and Current Consumption for Key Components 
Mode BGM121 AD5933 AD2S99 Current (mA) Output 
Sensing ON ON OFF ~25 2 kHz, 
0.600 mV 
Treatment ON OFF ON ~40 20 kHz, 
0.650 mV 
Shutdown ON OFF OFF ~<1 NONE 




Figure 3-12: Circuit diagram for the PCB incorporating Bluetooth MCU, impedance sensing module, and 
sine wave oscillator for wireless detection and treatment of bacterial biofilms on catheters [169]. 
Figure 3-12 depicts the circuit diagram for the custom PCB. The MCU connects to the 
AD5933 impedance sensing module via an I2C serial interface. The AD5933 is responsible for 
generating a 2 kHz, 0.600 mV signal across the flexible electrode and digitizing the sensor 
impedance output using a built-in analog-to-digital-converter for data acquisition. The AD5933 is 
configured, per the datasheet [179], to measure small impedances (< 1 kΩ) by placing op-amps at 
the Sensor Excite pin to amplify the excitation signal and at the Sensor In pin to properly bias the 
signal. More specifically, the op-amp at the AD5933 output is a non-inverting buffer, and the op-
amp at the AD5933 input is in an inverting configuration with a gain of 10. In this case, the 
AD5933 is setup to measure impedance at a single frequency, 2 kHz. For the treatment circuit, the 
AD2S99 is configured to create a 0.650 Vpk-pk sine wave with a 2.5 V DC offset, which is applied 
via a voltage divider circuit. An op-amp buffer is used to isolate the output of the oscillator from 
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the current load of the biofilm electrodes. Voltage controlled switches are used to alternate the 
signals going to the biofilm electrodes between those needed for the AD5933 (sensor in/sensor 
out) and those needed for the AD2S99 (oscillator output and ground). This fully isolates both 
circuits from the electrodes when the other circuit is being used. Voltage regulators are used to 
generate 3.3 V, 5 V, and -5 V, which are needed to drive each of the components. To conserve 
power, power switches (TPS22810, Texas Instruments) are used to turn off the power going to 
either the sensing or treatment circuits when not in use. 
The entire circuit is laid out on a 15.5 mm wide by 37 mm long (Figure 3-2 (a)) custom 
four-layer FR-4 PCB using Eagle AutoCad (Autodesk). Per the datasheet for the BGM121 [178], 
specific considerations are required to ensure that the on-package antenna can operate efficiently 
and propagate the 2.45G Hz wireless signal. Major considerations for the board layout that directly 
relate to propagation distance are the placement of the chip (i.e., centered with the edge where the 
antenna is located next to the board edge) and the ground plane clearance areas in the board layers 
surrounding the antenna (to avoid a short). The signal transmission was assessed using received 
signal strength indicator (RSSI), where decreasing values correspond to decreasing signal strength. 
The BGM121 antenna has a sensitivity of -90 dBm; if the RSSI is any lower, the signal is no longer 
being received reliably. Taking these considerations into account, the board is able to transmit a 
Bluetooth signal to a smartphone at a distance of at least 40 meters within a hallway in our 
laboratory building (Figure 3-13). This result supports the wireless use of this system in a similar 




Figure 3-13: Bluetooth transmission relative signal strength (RSSI) between phone and PCB measured in 
laboratory building hallway (N = 3) [169]. 
The MCU is used to program the AD5933 via the I2C interface per the datasheet [179] for 
configuring the start-up and measurement sequence and to read the data stored within the device 
registers. A frequency sweep is used to obtain the necessary impedance data, with the measured 
impedance value recorded at 2 kHz. This was selected to be above the lowest frequency that could 
reliably be measured using the AD5933. Briefly, commands formatted as 8-bit words are sent to 
the AD5933 in the following sequence to initiate a frequency sweep. (1) The start frequency, 
number of frequency increments, and the frequency increment are programmed, (2) the AD5933 
is placed in standby mode, (3) the AD5933 is initialized with a start frequency command, and (4) 
the start frequency sweep command is sent after a specified settling time. (5) The MCU then polls 
a status register to see if the frequency data is present. (6) If data is present, the impedance value 
is read from the AD5933 and (7) the MCU polls the status register to see if the frequency sweep 
is complete. (8) If it is not complete, the frequency is incremented and the measurement is repeated 
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starting with step (5), and if the frequency sweep is complete the AD5933 powers down. A key 
consideration for the impedance measurement circuit is the calibration of the AD5933. This is 
accomplished using resistors with known impedance values, as described in the AD5933 datasheet 
[179]. 
3.3.1.1 Impedance converter biofilm sensing 
The AD5933 impedance converter was utilized to miniaturize the impedance sensing 
functions of this system. The first step towards implementing this component was verifying its 
capability for biofilm sensing. This was evaluated using the setup described in Figure 2-3. Real-
time impedance monitoring was performed with the AD5933 impedance converter. The 200 mV 
impedance at 1 kHz was measured every 2 minutes by connecting the device leads to the AD5933 
on the UG-364 evaluation board (Analog Devices), utilizing the accompanying evaluation board 
software. The different sensing parameters were selected due to the limitations of the evaluation 
board and AD5933. The 200 mV was the minimum excitation signal possible with the board, and 
1 kHz was the minimum frequency that could be reliably measured using the AD5933. 
Impedance changes measured with the AD5933 impedance converter are depicted in 
Figure 3-14. The trends produced reflect the similar sensing characteristics measured with the 
potentiostat for both control and biofilm samples. The biofilm-free samples yielded a slight 
increase in impedance, after the 24-hour growth period, of approximately 2%. By comparison, 
biofilm formation led to a drop of about 5% in the measured impedance after 24 hours of growth. 
The most notable difference between the results with the AD5933 and the standard benchtop 
potentiostat is the decreased magnitude of the changes in impedance for both samples. The signal 
change equated to only 16% of the average percent change seen in Figure 2-7 over the same period 
using the potentiostat. This decreased sensitivity is likely attributed to differences in system 
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calibration and variations in impedance of the measurement electronics. It is also important to note 
that the frequency used in this case was higher (1 kHz versus 100 Hz in previous setup) and 
therefore, may be less sensitive to biofilm formation. Nonetheless, the similar trend versus the 
standard indicates that biofilm detection with AD5933 is feasible. 
 
Figure 3-14: Percent change in 200-mV impedance at 1 kHz measured with the AD5933 impedance 
converter for biofilm (green) and control (pink) samples over a 24-hour growth period, showing a steady 
drop associated with biofilm growth. The large standard error indicates the high inherent variability of 
biofilm formation (N = 3) [148]. © 2018 IEEE 
CVS was also performed per the procedure described in Chapter 2 to quantify the end-
point biomass for samples measured with the AD5933 to correlate the change in impedance with 
an increase in biomass from biofilm. The biomass quantification results for samples measured with 
the AIC are shown in Figure 3-15. These samples displayed a significant increase in biomass 
associated with the formation of biofilm compared to biofilm-free controls, similar to the 
potentiostat measured samples. The increased absorbance was statistically significant compared to 
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LB media alone, according to one-way ANOVA (p < 0.05). This indicates that the decrease in 
impedance is correlated with an increase in biomass, as described in Chapter 2. This further 
confirms the viability of this device combined with the AD5933 for wireless biofilm monitoring. 
 
Figure 3-15: End-point biomass quantification for samples with and without biofilm measured with the 
AD5933. Error bars correspond to standard error (N = 2), *Significance P < 0.05 [18].  
Initial characterization of this platform utilized a benchtop potentiostat for performing 
impedance measurements. However, bulky wired equipment is impractical for applications 
involving inserted medical devices. Here, I demonstrate biofilm detection using the AD5933 to 
help miniaturize the electronics and overcome this challenge. The AD5933 can be programmed 
with a BGM121 Bluetooth microcontroller to run impedance measurements and transmit the data 
wirelessly. The AD5933 was demonstrated as a viable approach for measuring biofilm formation 
with this device. Compared with the potentiostat standard, the AD5933 demonstrated reduced 
sensitivity, but the impedance converter successfully measured a decrease in impedance with 
biofilm formation which correlated with an increase in biomass.  
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3.3.2 Biofilm management mobile application 
Facilitating the use of this system in research and healthcare requires a simple and user-
friendly interface that can be used without any prior expertise. To operate the system, a custom, 
user-friendly mobile application was developed to wirelessly control the PCB and export and 
display data. The application has both iOS and Android compatible versions and is designed to 
send commands to the PCB to transition between Sensing, Treatment, and Shutdown modes. In 
addition, the application reads the raw values from the AD5933 and displays the calculated 
impedance. Figure 3-16 depicts each of the screens of the application. The application also displays 
whether the impedance values have surpassed a threshold value that is set by the user to indicate 
bacterial growth. Overall, this application allows user-friendly control, which facilitates 
widespread implementation of this tool in research and clinical settings. 
After pairing with a device, the device details are shown via a dropdown menu of 
commands that can be sent to the device, including, Take Measurement, Initiate Treatment, 
Shutdown, Set Threshold, and Set Gain, summarized and shown in Figure 3-16. Take 
Measurement begins the impedance sensing, Initiate Treatment prompts the system to output a 
sine wave for treatment, Shutdown turns off all functions to save power, Set Threshold determines 
a relative change in impedance, which will trigger a notification in the application, and Set Gain 
sets the gain factor used to calibrate the sensor via the process described in the AD5933 datasheet 
[179]. The gain factor and feedback resistor (RFB) used for these experiments, as well as the 
threshold, are listed in Appendix C.1. 
Updates to the measurement parameters, impedance values, and connecting and 
disconnecting events are recorded in the activity log on the device details screen. This screen also 
indicates whether the impedance has surpassed the threshold set by the user.  The chart icon will 
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display a chart depicting all of the recorded measurements over time for the currently connected 
device. When in the pairing screen, the export data feature allows all of the data contained in the 
activity log to be exported in a spreadsheet. This includes the type of command, impedance data, 
raw values, time stamps, and device names. A representative export file is shown in Appendix C.2. 
After pairing with a device, the device details screen allows control via a dropdown menu 
of commands that can be sent to the device, summarized below. 
i. Take Measurement 
This allows a user to take a measurement. When the use selects this command and clicks 
Send, an input box is displayed. This allows the user to specify how many measurements they 
want to take and how long the application should wait in between taking measurements. The input 
format is: [Iterations]*[Duration]. 
ii. Initiate Treatment  
This allows a user to initiate the electric field for treatment. The treatment will continue 
until either a “Take Measurement” or “Shutdown” command is issued. The user enters the duration 
of the treatment signal before a “Take Measurement” command is initiated, thus stopping the 
treatment. 
iii. Shutdown  
This allows the user to put the device into shutdown mode, reducing current draw to <1 
mA. This causes the device to stop ongoing measurements and toggle power switches to the 
AD5933 and AD2S99 using less power; however, it is still able to receive commands. An “Initiate 
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Treatment” or “Take Measurement” command will cause the device to come out of sleep mode 
and perform the action being requested. 
iv. Set Threshold 
This allows the user to specify a threshold impedance value, which will trigger a 
notification in the application with the value displayed in red font in the activity log. 
v. Set Gain 
This allows the user to specify the gain factor to be used when calibrating the impedance 






Figure 3-16: Mobile application for user-friendly infection management. (a) Splash screen when opening 
the application. (b) Devices available for pairing, including device name and unique identifier. The upper 
right corner contains the button for data export. (c) Device details home screen after successful pairing. 
This includes the activity log that records each action, graph button, and drop-down menu for sending 
commands. (d) Menu of all commands. (e) Take measurement command interface for performing 
impedance measurements. The first number corresponds to the number of measurements and the second 
number corresponds to the interval in seconds between each measurement. (f) Display of impedance results. 
R is the real component of the impedance, I is the imaginary component of impedance, and C is the total 
impedance value. Green indicates the initial value, red a value under the threshold, and black a value above 
the threshold. (g) Initiate treatment interface, showing timer for the duration of the electric field application 
in seconds. (h) Activity log showing treatment in progress with timer. (i) Interface to set threshold for 
impedance change in percent. This indicates a user-defined change in impedance below which there may 
be an infection risk. (j) Command interface for setting the gain factor for impedance sensing calibration. 
Value is x10-6. (k) Activity log showing shutdown command. (l) The options for the graph interface, plotting 
the relative percent change in impedance over different intervals. (m) Example plot of four measurements 
[169]. 
3.4 Synopsis/Summary 
In this chapter, I have introduced two distinct approaches for integrating sensing and 
treatment electrodes with a commercially available Foley catheter. The first approach utilizes a 
3D-printed insert, with the flexible electrode rolled and inserted, that interfaces with a cut in the 
catheter. This approach was relatively robust, allowing both the drainage and anchoring catheter 
functions to be performed normally. In addition, the materials used for this approach were not 
found to generate cytotoxic leachates. As an alternative integration approach, I developed a 
fabrication process utilizing electroless plating and electroplating to generate electrodes directly 
on the surface of the catheter lumen. Patterning these electrodes was made possible by inserting 
3D-printed scaffolds to screen certain areas from the plating solution. These electrodes were shown 
to be capable of impedance sensing comparable to the impedance sensing seen with the proof-of-
concept system from Chapter 2. Finally, I also introduced the electronics system developed to 
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wirelessly control the catheter device. This includes the PCB containing off-the-shelf components 
for both sensing and treatment, along with the mobile application for wireless control in a user-
friendly manner. The contributions from this chapter demonstrate integration of sensing and 





Chapter 4: Biofilm Management in Synthetic Bladder Environment 
In order to advance this technology towards implementation in an in vivo or clinical setting, 
this system first needs to be demonstrated under realistic conditions. The in vitro test conditions 
utilized to evaluate this system in the last two chapters lack certain key aspects of the catheterized 
bladder. Notably, the results have been impacted by an unrealistic biochemical environment. The 
LB media utilized to test the sensor response to biofilm growth contains more and different 
nutrients than are generally present in human urine. This can lead to dramatic differences in how 
bacteria grow and form biofilms [181], [182]. In addition, the ions present in the solution interact 
directly with an electrochemical impedance sensor, changing the baseline impedance 
characteristics. Furthermore, the conditioning layers that form on the electrodes with each solution 
will be different due to the varying chemical compositions. 
The physical environment also impacts the functionality of this system. In particular, a low 
and constant flow rate has been used previously when characterizing this system. In reality, 
urination patterns are highly variable, with long periods of no flow separated by periodic voiding 
[183]. My previous studies using this device have focused on biofilm growth exclusively on the 
inner lumen of the catheter, where the sensor is placed. While this is the area most commonly 
colonized by biofilm [168], an indwelling catheter is typically inserted into the bladder where the 
outer surface is immersed in urine and can become colonized as well. The bladder itself can also 
be colonized by bacteria [10]. 
In this chapter, I introduce a synthetic bladder model that I developed to characterize the 
integrated system in a more realistic environment. This model relies on artificial urine to recreate 
(1) the biochemical environment for biofilm growth that is more clinically relevant. Artificial urine 
media has a more realistic concentration of nutrients and ions that should lead to a closer 
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approximation of clinical biofilm growth. This model also consists of a silicone bladder to 
recapitulate (2) the physical environment of the catheterized bladder. The bladder with the system 
inserted forms a flow system that is driven by a programmable peristaltic pump, enabling the 
system to be studied under variable flow conditions, notably long periods of stagnant flow 
followed by brief periods of higher flow associated with voiding. The bladder also forms a 
reservoir with realistic geometry that can be colonized by bacteria. Using this synthetic model, I 
evaluate each of the key functions of the integrated biofilm management system in a realistic 
environment. First, I examine biofilm sensing in this model using the prototype. Then, I evaluate 
the BE-based treatment efficacy. The results from these efforts will help to demonstrate that this 
is a viable approach for biofilm management in a catheterized bladder as well as facilitate future 
in vivo and clinical studies. In addition, the model developed here can also be utilized as an in vitro 
model for other urinary catheter devices. 
I am grateful to Dr. Sangwook Chu for his help designing the realistic bladder model. 
4.1 Bacterial Growth Sensing in Realistic Model 
Typically, novel catheter anti-infection strategies are evaluated using small portions of the 
material inoculated with bacteria and are analyzed using traditional imaging or colony counting 
[123], [184]. Alternatively, murine models of urinary catheterization have been developed, which 
involve implanting pieces of a catheter in the bladder of a mouse [181], [185]. Rabbit models have 
also been utilized for evaluating novel urinary catheters [186], [187]. A prominent example of an 
in vitro bladder model was developed by Stickler et al and consisted of a 200 ml glass vessel 
maintained at 37 °C with a water jacket to study the encrustation of urinary catheters by Proteus 




As introduced at the start of this chapter, the bladder model is comprised of a silicone 
model of the human bladder and artificial urine. Once the Foley catheter with the integrated biofilm 
management system is inserted, this model recreates several key biochemical and physical 
characteristics of the catheterized bladder. The impact on impedimetric sensing is explored in 
detail in this section utilizing this realistic testing platform. This represents a key demonstration of 
the integrated wireless sensing capabilities with bacterial growth that is more likely to resemble 
growth in a CAUTI with the sensor electrodes immersed in urine. 
This section describes the synthetic bladder model in significant detail. Then, I use this 
model to evaluate impedance sensing of Escherichia coli under two different flow conditions: 
constant flow and pulsatile flow designed to recreate the variable flow associated with the filling 
and draining of the artificial urine from the bladder. Combined, these studies support the feasibility 
of this integrated system for use in bladder environments.  
4.1.1 Materials and methods 
The modified catheter biofilm management system was evaluated in a synthetic bladder 
model. Figure 4-1 depicts the synthetic bladder setup, consisting of a 3D-printed silicone human 
bladder, the inserted modified catheter system, and artificial urine all maintained at 37 °C in an 
environmental chamber. This synthetic model recapitulates the biochemical environment for 
bacterial growth via artificial urine, and the programmable peristaltic pump recapitulates the 
physical flow conditions found in the catheterized bladder. Utilizing artificial urine promotes 
bacterial growth that is more similar to what is seen in the clinic. This artificial urine media was 
based on human urine samples and designed to study the growth of urinary pathogens [189]. 
A 3D-printed silicone model of the human bladder (Lazarus 3D) recreates the physical 
urine storage/flow system where urinary catheters are inserted. This model has a volume of 350 
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ml, two ureters, and a urethra. The catheter is inserted into the urethra so that urine may drain, and 
the balloon may be inflated. One ureter serves as a valve to drain the bladder at the conclusion of 
the experiment, and the other serves as an inlet to introduce artificial urine at a fixed rate. The 
tubing connected to the bladder is interfaced with a peristaltic pump that drives the flow. The flow 
can be maintained at a steady rate or programmed to flow in intermittent pulses. The bladder with 
inserted catheter system, tubing, and media reservoirs are autoclaved (20 min, at 121 °C) to ensure 
sterilization. 500 ml of artificial urine (Table 4.1) is added to the artificial urine reservoir in a 
sterile biosafety cabinet. The artificial urine is filtered with a 0.2 µm PES syringe filter (VWR) to 
prevent contamination. The complete flow system has ports on both the urine and waste reservoirs 
with syringe filters to maintain sterility and equalize the pressure during flow experiments. The 
flow system is placed in an environmental chamber at 37 °C to maintain the temperature and 
minimize the risk of outside contamination. The pump and urine reservoir are connected to the 
bladder/catheter system via tygon tubing and stored outside of the environmental chamber. The 
bladder was left overnight to fill with urine, until the catheter was fully immersed, before growth 




Figure 4-1: Overview of synthetic bladder model setup [169]. 
Chemical Component Concentration 
Peptone 1 g/L 
Yeast Extract 5 mg/L 
Lactic Acid 100 mg/L 
Citric Acid 400 mg/L 
Sodium Bicarbonate 2.1 g/L 
Urea 10 g/L 
Uric Acid 70 mg/L 
Creatinine Hydrochloride 900 mg/L 
Calcium Chloride Dihydrate 370 mg/L 
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Sodium Chloride 5.2 g/L 
Iron (II) Sulfate 1 mg/L 
Magnesium Sulfate Anhydrous 240 mg/L 
Sodium Sulfate Decahydrate 3.2 g/L 
Potassium Phosphate Monobasic 950 mg/L 
Potassium Phosphate Dibasic 1.2 g/L 
Ammonium Chloride 1.3 g/L 
Table 4-1: Composition of artificial urine for bladder model. Artificial urine was made using deionized 
water [169]. 
Biofilm detection experiments were performed using the aforementioned bladder model. 
An Escherichia coli K12 W3110 bacterial culture was prepared in 5 ml of artificial urine and 
cultured overnight (37 °C, 120 rpm) in an incubator shaker (Brunswick Instruments). A 1:100 
dilution of this culture was then grown overnight and diluted relative to artificial urine without any 
bacteria added. 1 ml of this solution at a dilution of OD600nm = 0.05 was added to the system at the 
start of the experiment. An initial measurement at t = 0 was taken using the mobile application 
immediately before adding the bacteria. Control samples were made without any bacteria added 
and 10 µg/ml gentamicin to ensure that there was no contamination throughout the experiment. 
For the constant flow samples, continuous measurement of the impedance was performed every 
30 min throughout the growth period. Measurements for the pulsatile flow samples were taken 
every 10 min for 10 hours. The change in impedance was recorded as a percentage relative to the 
initial impedance value (equation 2.1) to account for small discrepancies between the starting raw 
impedance values of different sensors. Another end-point impedance value was recorded after 24 
hours of growth.  The adhered biomass was determined using a crystal violet absorbance assay at 
the conclusion of the pulsatile flow experiment. This consisted of filling the catheter and insert 
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completely with 0.1% crystal violet solution. The crystal violet was bound with the biofilm 
material on the surface of the catheter and insert for 15 min. The solution was then drained from 
the catheter and the system was then rinsed with 10 ml of deionized water to remove excess stain. 
The insert was carefully removed from the catheter and immersed in 35 ml of decomplexation 
solution (1 acetone: 4 ethanol) for 35 min. The decomplexation solution dissolved the bound stain, 
and the OD590nm of the resulting solution corresponds to the relative biomass adhered on the insert 
with and without biofilm.  
One-way ANOVA was performed to evaluate the significance of the impedance sensing 
results. 
4.1.2 Impedance sensor characterization in synthetic model 
Figure 4-2 (a) is a representative plot of the impedance change recorded every 30 minutes 
for 24 hours with Escherichia coli added under constant artificial urine flow of 7 ml/h using the 
realistic bladder model. The impedance decrease is initially more rapid immediately following the 
addition of the bacteria at t = 0 and then slows after the first 6.5 hours. The relative percentage 
impedance change decreases by approximately 4.2% over the first 6.5 hours for a rate of -0.65%/h. 
The decrease then slows, decreasing an additional 2.4% over the next 17.5 hours for a rate of -
0.14%/h. This parallels the growth of the bacteria, with a rapid exponential growth phase followed 
by a plateau [190].  The end-point impedance sensing results show a 13.0% decrease when bacteria 
are added versus a 5.4% increase for the negative control (Figure 4-2 (b)), demonstrating the 
viability of this system as a detection tool for the presence of bacteria on an inserted urinary 
catheter in an artificial urine environment. This trend is similar to what was seen in previous 
sections in standard LB media; the reduced magnitude and rate of the impedance change in this 
work is attributed to the lower concentration of nutrients in artificial urine, leading to decreased 
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bacterial growth. The decrease in impedance seen in Figure 4-2 arises due to the metabolism of 
growing bacteria on and near the surface [15]. An important consideration for this work moving 
forward is relating the magnitude of impedance change to real CAUTI outcomes, to identify a 
threshold that is truly indicative of infection. This should include a calibration curve to equate the 
average impedance change with the bacterial concentration on the surface, as well as biomass. The 
slight increase seen in the bacteria-free negative control is due to the formation of small bubbles 
on the sensor surface over time, which is driven by the temperature difference between the bladder 
model (37 °C) and the artificial urine reservoir (room temperature) [189]. The bubbles do not 
interact with the sensor when bacteria are present due to a layer of biofilm forming on the surface.  
 
Figure 4-2: (a) Representative real-time relative change in 2 kHz impedance, showing decrease during 
bacterial growth. (b) End-point relative change in impedance after 24 hours of growth. Control N = 3, 
Bacteria N = 8, *Significance P<0.05 [169].  
4.1.3 Impedance sensor characterization under pulsatile flow 
The synthetic bladder model can be utilized to recreate both the biochemical and physical 
characteristics of the catheterized bladder. Figure 4-3 (a) presents a representative sample of the 
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impedance recorded every 10 minutes for 10 hours while the sample was subjected to a pulsatile 
flow pattern that mimics periodic filling of the bladder, followed by catheter drainage. The catheter 
remained filled with artificial urine throughout the experiment. However, 21 ml flowed every three 
hours in a pulse, with a flow rate of 5 ml/min, allowing the system to be evaluated under realistic 
and variable flow conditions. The sample initially displays a higher degree of variability in the 
impedance change, which is attributed to the lack of a significant biofilm on the surface and 
inconsistent growth stemming from the static flow between drainage events. However, over time 
the signal becomes more consistent. The impedance decreases approximately 10.8% over the 10-
hour period shown in Figure 4-3 (a). The end-point results in Figure 4-3 (b) display the relative 
change in impedance after 24 hours of pulsatile flow. The relative decrease in impedance of 
approximately 20.0% for the samples with bacterial growth compared to a 4.3% increase for the 
negative control confirms that this system reliably functions as an impedance sensor for monitoring 
bacterial growth in urinary catheters under realistic flow conditions. The crystal violet absorbance 
assay adhered biomass measurements in Figure 4-3 (c) further corroborate this implication, 
demonstrating a correlation between the impedance decrease and an increase in biofilm growth. 
These results imply that the system functionality is maintained under the variable and realistic flow 




Figure 4-3: (a) Representative real-time 2 kHz relative change in impedance, showing decrease with 
bacterial growth under pulsatile flow conditions. Dashed blue lines correspond to flow pulses. (b) 
Representative end-point relative change in impedance for bacterial growth and control samples under 
pulsatile flow. (c) Biomass staining corresponding to samples with and without bacteria under pulsatile 
flow, showing a correlation between increased biomass and decreasing impedance (N = 2) [169]. 
This set of studies demonstrates that these impedimetric sensors function in artificial urine 
comparably to LB media. Furthermore, variable flow patterns do not significantly alter this 
function. It is notable that the magnitude of these changes are smaller, but this is primarily 
attributed to differences in growth by bacteria in each solution. In vitro studies like this are 
invaluable to decrease the risk associated with this approach before time, labor, and cost-intensive 
in vivo or clinical trials are undertaken. 
4.2 BE Treatment Efficacy 
An essential function of this system is the effective treatment of biofilm once growth has 
been identified. To achieve this goal and help reduce the incidence of CAUTI, this system can be 
utilized to administer the BE. The BE can reduce the dosage of antibiotics needed for infection 
clearance and mitigate the spread of antibiotic resistance. The catheterized bladder environment 
presents a significant challenge for implementing this approach. The electric field interacts with 
all of the components of the urine, and electrochemical generation of reactive compounds may 
play a role in the efficacy of the BE. For this reason, changing the media could change the efficacy 
of the treatment. As noted previously, the different media changes how the bacteria grow, which 
can also change their susceptibility to treatment. 
In this section, I examine the efficacy of the BE utilizing the integrated catheter system in 
the synthetic bladder model described in the first half of this chapter. I examine both the planktonic 
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cell counts and biomass adhered to the sensor surface to quantify the impact of the BE under these 
realistic conditions. 
4.2.1 Materials and methods 
After this growth period, one of four different conditions were set for the treatment period: 
(1) no additional treatment (untreated and unseeded negative control), (2) 10 µg/ml gentamicin 
and continuous 650 mV, 20 kHz AC signal (BE), (3) 10 µg/ml gentamicin (antibiotic-only), and 
(4) continuous 650 mV, 20 kHz AC signal (electric field-only). After the treatments had been 
applied for 24 hours, the end-point impedance was measured using the mobile application and 
recorded relative to the impedance at the start of the treatment period. At each end-point, the 
planktonic cell counts were recorded by taking approximately 0.5 ml from the outlet, performing 
a serial dilution, and counting the CFU/ml on agar plates. The CFU/ml change due to each 
treatment was determined relative to the CFU/ml found at the beginning of the treatment period, 
to evaluate the impact that each treatment has on the growth of planktonic bacterial cells. The 
adhered biomass was determined using the CVS assay described in section 4.1.1. This consisted 
of filling the catheter and insert completely with 0.1% crystal violet solution. The crystal violet 
was bound with the biofilm material on the surface of the catheter and insert for 15 min. The 
solution was then drained from the catheter and the system was then rinsed with 10 ml of deionized 
water to remove excess stain. The insert was carefully removed from the catheter and immersed 
in 35 ml of decomplexation solution for 30 min. The OD590nm of the resulting solution corresponds 
to the relative biomass adhered on the insert for each of the treatment conditions, to determine the 
efficacy with regards to biofilm reduction. 
One-way ANOVA was performed to evaluate the significance of the biomass 
quantification and CFU/ml results. 
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4.2.2 BE treatment efficacy 
Following the growth of bacteria in the catheterized bladder model for 24 hours, this system 
enables BE-based treatment to remove biofilms adhered to the catheter surface. The resulting 
biofilm biomass at the end of 24 hours of treatment was evaluated using a crystal violet absorbance 
assay (Figure 4-4 (a)), showing highest optical density for untreated samples (OD590nm = 
0.333±0.017). This degree of biofilm formation was comparable to those samples treated with 
gentamicin-only or electric field-only (OD590nm = 0.332±0.027 and OD590nm = 0.324±0.025, 
respectively). This result for biofilm in artificial urine is consistent with previous in vitro results 
demonstrating that an electric field with this intensity, or gentamicin at this concentration, has 
limited efficacy for biofilm reduction. Furthermore, the BE (i) showed significantly (P<0.05) lower 
biomass (OD590nm = 0.278±0.010) than the untreated (ii) samples, displaying a synergistic 
reduction in biofilm using this system. This contrasts with the relative ineffectiveness of the 
gentamicin (iii) and electric field (iv) treatments for reducing biofilm. The negative control (v) 
measurement (OD590nm = 0.261±0.024) served as a baseline for comparison; the relatively high 
baseline signal is driven by precipitates which form in the artificial urine media at 37 °C [189]. It 
should be noted that the biomass quantification focused on the sensor insert where the electric field 
was present. The efficacy of this approach would likely improve by having the electrodes act on a 
higher percentage of the vulnerable surface. 
In addition to biofilm biomass evaluation, the change in CFU/ml during each of these 
treatments was also examined in Figure 4-4 (b). It is important to consider both, as planktonic cell 
growth and surface-associated biofilm growth contribute to CAUTI. Expectedly, the planktonic 
bacterial counts rose significantly over the 24 hours of treatment for untreated samples (ii). 
Similarly, the electric field-treated samples (iv) showed an increase in bacterial cells comparable 
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to the untreated control, as the electric field only acts on a small portion of the catheter surface and 
is shown to have limited impact on cell viability [17]. Gentamicin-only (iii) shows a significant 
(P<0.05) decrease in planktonic cells relative to the untreated samples, as these cells are not as 
tolerant of antibiotic therapy as cells in a biofilm are. The BE (i) shows the most significant 
(P<0.05) reduction in planktonic cells relative to the untreated samples, changing from an increase 
of 1.19 × 107 CFU/ml for the untreated samples to a decrease of 3.08 × 106 CFU/ml for the BE 
samples. This is attributed to the combined impact of the antibiotic on the planktonic cells and the 
synergistic impact of the electric field and gentamicin on the biofilm on the insert surface. It is 
essential to address both surface-associated and planktonic bacterial growth when developing tools 
for CAUTI management. In this case, both the surface associated biomass and planktonic bacteria 
show significant reductions with the BE application. These results, in combination, demonstrate 
this integrated system as a viable approach for applying the BE in the catheterized bladder 
environment and reducing the impact of Escherichia coli infection. As was mentioned at the 
conclusion of section 4.1, it is important to perform these in vitro studies under realistic conditions 
to better identify potential pitfalls and risks for future implementation of this system in a clinical 
or in vivo setting. These results suggest that the BE may be a viable strategy for this application; 
however, additional research needs to be performed for other antibiotics and organisms that are 
more relevant for CAUTI, such as trimethoprim-sulfamethaxole and uropathogenic Escherichia 




Figure 4-4: (a) End-point biomass staining corresponding to each treatment after the 24-hour treatment 
period and (b) the change in CFU/ml for each treatment during this period. This shows the lowest biomass 
for the BE treatment, as well as the largest decrease in CFU/ml. i- BE treated samples (N = 3 (a), N = 3 
(b)), ii- untreated samples (N = 3 (a), N = 3 (b)), iii- gentamicin-only treated samples (N = 3 (a), N = 3 (b)), 
iv- electric field-only treated samples (N = 3 (a), N = 3 (b)), and v- negative control without bacteria (N = 
4 (a), N = 3 (b)). *Significance P<0.05 [169]. 
4.3 Synopsis/Summary 
In this chapter, I developed a synthetic bladder model for evaluating the performance of 
the integrated biofilm management system. This model, comprised primarily of a silicone bladder 
and artificial urine, recreated many of the biochemical and physical characteristics that this system 
would encounter in vivo. I demonstrated impedance sensing of bacterial growth using this system 
in the synthetic model under both constant and variable flow conditions. Subsequently, I was able 
to treat these biofilms under realistic conditions using the BE, showing significant reduction in 
both adhered biomass and planktonic cells. Taken together, the contributions from this chapter 




Chapter 5: Concluding Remarks 
5.1 Highlights 
There were several highlights associated with the fabrication and testing of proof-of-
concept flexible sensor electrodes for biofilm detection and BE-based treatment described in 
chapter 2: (1) I fabricated IDEs on a flexible polyimide substrate that seamlessly conforms with a 
cylindrical catheter surface, (2) I demonstrated real-time impedimetric sensing of biofilm growth 
on a cylindrical surface, and (3) I correlated the application of the BE using the flexible device 
with a reduction in strongly adhered biomass. 
Another highlight from chapter 2 was the evaluation of the impact of varying curvature on 
impedance sensor performance. I (1) compared impedimetric sensing and BE treatment in vitro at 
three different curvatures and (2) examined the sensor response of electrodes in planar and 
cylindrical conformations using commercial simulation software. 
There were several key highlights from the integration of electrodes with the 
commercially-available Foley catheter for biofilm monitoring. I developed two different strategies 
for electrode integration with urinary catheters: (1) a 3D-printed insert containing flexible 
electrodes and (2) direct plating of electrodes onto urinary catheters. In addition, I verified that the 
standard catheter functions are maintained with the integrated device and evaluated the 
biocompatibility of 3D-printed insert materials. 
The development of the electronic systems for control of integrated biofilm management 
device also yielded several highlights. I (1) demonstrated detection of biofilm using off-the-shelf 
electronic components, (2) developed a miniaturized PCB for wireless detection, treatment, and 
data transmission, and (3) developed a mobile application that enabled user-friendly system control 
and data display. 
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There were a number of highlights associated with the testing of the integrated system for 
monitoring and treatment in a realistic in vitro bladder model. I (1) assembled a realistic laboratory 
model of the catheterized bladder for in vitro system evaluation, demonstrated real-time 
impedimetric sensing of bacterial growth under realistic conditions using the integrated system, 
and utilized the integrated system in the bladder model to effectively implement the BE. 
5.2 Summary 
This dissertation presents the development of an integrated, microsystems-based approach 
for addressing the challenge of CAUTI. The progression from a proof-of-concept device to an 
integrated system in a realistic laboratory bladder is illustrated in Figure 5-1. I adapted a previously 
developed LOC biofilm characterization platform using a flexible substrate in Chapter 2, allowing 
the electrodes to be conformed on the inner lumen of a catheter while maintaining functionality. 
This device detected biofilm growth in real-time through impedimetric sensing. The same 
electrodes were then utilized to achieve a reduction in adhered biomass via the BE. Chapter 3 then 
described the integration of this device with a commercially available Foley catheter. Two 
different approaches were explored: (1) a 3D-printed insert module containing the flexible sensor 
integrated with the catheter at a transverse cut and (2) plating electrodes directly on the surface of 
the catheter. In addition to the physical integration of the electrodes, the development of the 
associated electronic systems was described in this chapter. This included a PCB for wireless 
sensing and treatment using off-the-shelf components and the mobile application. Combined, the 
PCB, mobile application, and integrated electrodes comprise the integrated catheter biofilm 
management system. In Chapter 4, this integrated system is tested in a custom synthetic bladder 
model to carefully evaluate the sensing and treatment functions under realistic conditions. The 
result is an integrated system that can support future research in vivo and in a clinical setting 




Figure 5-1: Illustration of system development in this dissertation from (a) proof-of-concept device to (b) 
integration with Foley catheter to (c) evaluation of sensing and treatment under realistic conditions. 
In Chapter 2, I developed a proof-of-concept biofilm sensing and treatment device and 
explored the impact of curvature on device performance. Notably, I fabricated IDE sensors capable 
of detecting biofilm formation using a flexible polyimide substrate. This substrate allowed the 
electrodes to be conformed in a cylindrical shape while maintaining the real-time sensing and BE 
treatment capabilities displayed in previous LOC systems [16]. Sensing was confirmed with 
significant differences in the impedance change with and without biofilm-forming bacteria and 
correlated with the adhered biomass. The reduction in biofilm via the BE was also confirmed via 
the decrease in adhered biomass relative to the controls without treatment, with only antibiotics, 
or with only the electric field. I utilized COMSOL modelling software and flexible sensors 
conformed at specified curvatures to investigate the impact that curvature has on these devices. In 
both cases, the change between planar and curved showed relatively little impact at the size scale 
that is relevant for urinary catheters, and this appeared to be true for both sensing and treatment. 
At a radius of curvature of 2.25 mm, the electric field distribution remained relatively unchanged. 
The device developed and evaluated in Chapter 2 was integrated with a urinary catheter in 
Chapter 3. Two different methods were investigated to achieve this goal. I developed a 3D-printed 
insert that accommodates the urine drainage and anchoring balloon inflation channels to ensure 
the proper catheter function was maintained. This insert housed the flexible sensor, which was 
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integrated with the catheter at a transverse cut near the distal tip. This approach allowed me to 
introduce the electrodes onto the vulnerable area of the catheter without altering the established 
design. I confirmed that the catheter maintained functionality by verifying liquid drainage and 
balloon inflation with the device integrated. I also evaluated the biocompatibility of the 3D-printed 
insert material to help ensure the safety of this technique for indwelling devices. As an alternative 
approach, I developed a fabrication process which relied on electroless plating with 3D-printed 
patterning scaffolds to produce isolated electrodes on the surface of a urinary catheter. SEM and 
EDS analysis confirmed that this process yielded a pair of electrodes on a section of a Foley 
catheter. These electrodes displayed impedance sensor performance that was comparable to 
flexible electrodes from Chapter 2 when exposed to Escherichia coli. The insert approach was 
utilized for subsequent experiments as it displayed better sensitivity due to the IDE electrode 
arrangement. An essential element of this system was the PCB and mobile application that were 
developed to provide user-friendly control and facilitate implementation by future researchers and 
clinicians. The developed PCB relied on COTS components to achieve wireless impedance sensing 
for biofilm detection and electric field generation for the BE in a small form factor that could be 
attached to the drainage bag of the catheter with minimal disruption for patients and healthcare 
practitioners. A mobile application was designed specifically to interface with this PCB, enabling 
seamless control over each of the functions as well as the data readout without specialized training. 
After the integrated system was developed, I investigated the use of this system under 
realistic bladder conditions. Artificial urine recreated the biochemical aspects of the bladder 
environment, while a 3D-printed silicone bladder with flow, controlled by a programmable 
peristaltic pump, recreated the physical aspects of this environment. Both the impedimetric sensing 
and BE treatment functions were explored under these conditions. I found that there was a real-
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time decrease in impedance associated with the addition of bacteria in this environment. While the 
trend was similar to the results from earlier chapters, the magnitude of the change was smaller due 
to decreased bacterial growth in the bladder setting relative to LB media. Future trials utilizing this 
system should focus on relating this change to real CAUTI outcomes, to help identify a threshold 
that is indicative of clinically relevant infection. The biofilm impedance sensing results in the 
realistic model were consistent under constant and variable flow. When the integrated system was 
utilized to administer the BE in the bladder model, I was able to show a decrease in both planktonic 
bacteria via colony counting and adhered biomass via CVS compared to untreated samples. This 
study forms the foundation for future research by demonstrating the feasibility of this system under 
realistic conditions. 
5.3 Future Work 
This dissertation project has laid the groundwork for new research directions that can be 
explored in the short- and long-term. These include enhancing the functionality of the system 
through sensor arrays, incorporating additional sensing modalities, and evaluating the system in 
vivo or in a clinical setting. Furthermore, this approach can be applied to many other applications 
that are susceptible to bacterial colonization, such as water systems and vascular catheters.  
5.3.1 Flexible electrode array for biofilm mapping on cylindrical surfaces 
The IDE-based impedance sensor provides a single readout for the entire surface. This 
provides significant utility for identifying general changes in the solution and on the surface. 
However, biofilm growth is spatially heterogeneous [192], including on the surface of urinary 
catheters [168]. As a research tool, it would be beneficial to improve the special resolution of this 
system by utilizing an array of IDEs distributed along the catheter surface.  Such a system can 
indicate the precise location of biofilm formation, which can help direct subsequent device design 
changes to address specific problem areas or highly targeted regions of treatment. Towards this 
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end, I adapted the flexible device concept from Chapter 2 into an array device with 8 spatially 
distinct sets of IDEs. 
The electrodes were fabricated on a flexible 25.4 µm-thick polyimide film that can be rolled 
and inserted to display the sensor surfaces on the interior of the urinary catheter. The fabrication 
process is displayed in Figure 5-2. In brief, electrodes were patterned via a transparency photomask 
(Figure 6-3 Appendix A) using photolithography. Metal (20 nm chromium/200 nm gold) was 
deposited via e-beam deposition, and liftoff in acetone formed the interdigitated electrodes (300 
µm width/spacing). The non-sensing areas were passivated with 2.5 µm of Parylene-C, which was 
removed from the sensor IDEs using protective polyimide tape. This final device (Figure 5-3) was 
comprised of eight interdigitated impedance sensors distributed over a 40 mm x 14 mm footprint. 
 




Figure 5-3: Optical image depicting fabricated sensor array on flexible polyimide film. The sensor consists 
of eight gold IDEs with a common ground. 
This system can be evaluated in vitro using the same setup utilized to characterize the 
flexible device in Chapter 2. Array devices like this should facilitate more detailed research into 
how biofilm grows on catheters and enable more precise interventions. 
5.3.2 Multimodal sensor system 
In addition to biofilm, there are numerous factors that contribute to and can help identify 
CAUTIs. An effective system for predicting CAUTI and negative infection outcomes should 
consider a panel of parameters to provide a more precise diagnosis and allow more effective 
treatment. These parameters include temperature, pH, and host inflammatory cytokines. An 
increase in body temperature, fever, is associated with CAUTI [193]. Changes in urine pH can be 
related to the formation of biofilm by Proteus mirabilis, which can lead to the development 
crystalline blockages in the catheter [10]. Inflammatory cytokines, such as interleukin 6, are also 
secreted during infection, making them a reasonable target for CAUTI detection [194]. 
A schematic of a pH, temperature, cytokine, and biofilm sensor integrated onto a single 
substrate is shown in Figure 5-4. Employing electrochemical sensors for pH [195], biofilm, and 
cytokines [196], as well as a resistive temperature sensor [197] facilitates integration of these 
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devices with electronic control systems that process electrical output signals. Further research is 
needed to more accurately assess the potential biomarkers associated with CAUTI and negative 
CAUTI outcomes, like pyelonephritis and sepsis. This research will undoubtedly guide the 
biomarker targets that this multimodal sensor system will be designed to detect. The cytokine 
sensor, particularly, can be easily modified by changing the biorecognition element affixed to the 
electrode surface. 
 
Figure 5-4: System schematic depicting multimodal sensor system with four different sensors for 
temperature, cytokines, biofilm, and pH, respectively. 
The development of a multimodal catheter-integrated sensor system will facilitate the 
acquisition of a diverse array of real-time and in situ data that is currently not available to CAUTI 
researchers. This system will be a focus of a collaborative National Institutes of Health RC2 
proposal between engineers in the Ghodssi group at the University of Maryland, College Park, Dr. 
Rena Malik, a urologist at the University of Maryland Medical School, and microbiologists Dr. 
David Rasko at the University of Maryland, Baltimore and Dr. Vincent Lee at the University of 
Maryland, College Park. The large quantity of data generated with this discovery platform can be 
analyzed using machine learning algorithms to identify new biomarkers indicative of CAUTI and 
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negative CAUTI outcomes. The data analysis portion of this project will be supported by Dr. Olga 
Goloubeva at the University of Maryland, Baltimore and Dr. Najib El-Sayed at the University of 
Maryland, College Park with expertise in biostatistics and bioinformatics, respectively. 
5.3.3 Biofilm sensing in clinical urine 
It is invaluable to evaluate the performance of the biofilm sensor in clinical urine samples 
from patients with indwelling catheters, as this will more accurately represent the conditions in a 
clinical setting or in vivo. The impedance sensor response to biofilm growth in clinical urine 
samples was evaluated with help from Anthony Chung using previously developed IDEs [16], 
which were integrated within a PDMS microfluidic channel (2 cm x 500 µm x 100 µm). A 
microfluidic device was used for this characterization, as the sample sizes were limited and 
insufficient for use with the bladder model in Figure 4-1. Patient urine samples were acquired from 
healthy, catheterized patients at the clinic of Dr. Rena Malik from the University of Maryland 
Medical School. These samples were frozen and transferred to the MEMS Sensors and Actuators 
Lab where they were stored at -80 °C. Prior to the experiments, the microfluidic systems were 
sterilized with 1 ml 70% ethanol flowed through the device at 100 µl/min using a syringe pump 
(Cole Parmer, 74900), followed by 5 ml of DI water at the same flow rate. The conditioning phase 
consisted of artificial urine being introduced into the device at 20 µl/h for 24 hours. This period 
allowed the formation of a conditioning layer and flushed any air bubbles out of the system. Patient 
urine was thawed and filtered with a 0.2 µm syringe filter (polyethersulphone, VWR) to prevent 
uncontrolled contamination by any bacteria already present in the sample. Escherichia coli K12 
W3110 were cultured from frozen in LB media overnight in an incubator shaker (Brunswick 
Scientific) at 250 rpm and 37 °C. The bacteria were then diluted to an OD600nm of 0.25 in the filtered 
patient urine. The urine sample spiked with bacteria was introduced into the microfluidic device 
at a flow rate of 100 µl/min. As a control, a urine sample without any bacteria added was also 
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introduced in another microfluidic device in parallel. Once the sample had filled the device, the 
flow was stopped, and the bacteria were allowed to attach within the device for the 2-hour seeding 
phase. Following the conclusion of the seeding phase, filtered patient urine without added bacteria 
was introduced into the device at a flow rate of 20 µl/h for 24 hours for the growth phase. 
Throughout the experiment, the impedance at 100 Hz and 5 mV was recorded using a potentiostat 
(660D, CHInstruments). The entire system was contained within an environmental chamber 
(Electro-Tech Systems, 5506) at 37 °C. Immediately following the growth phase, the sample was 
stained with LIVE/DEAD stain in tris buffer, prepared as described in Chapter 3. The stain was 
introduced into the channel at a flow rate of 20 µl/h for 18 hours so as not to disturb the attached 
biofilm. The sample was then rinsed with tris buffer at 20 µl/h for 24 hours to remove unbound 
stain. The samples were then imaged using a confocal microscope (LSM 700, Zeiss) to correlate 
the presence of biofilm with the impedance change. 
A representative sample, spiked with Escherichia coli, showed a notable decrease in 100 
Hz impedance over the 24 hour growth period (Figure 5-5). The impedance decreased 
approximately 8% over the first 12 hours, followed by a plateau. However, the control channel 
without any bacteria added also showed an impedance decrease of approximately 8%. These 
decreases are attributed to the fouling of the electrode by host proteins [10]. Only a small biofilm 
was identified in the microfluidic channel with bacteria added using confocal microscopy (Figure 
5-6). This aggregate of cells was sparse and mostly dead, as indicated by the dominance of the 
propidium iodide in the image. This likely contributed to the similarity between the control and 




Figure 5-5: 100 Hz, 5 mV impedance transients depicting relative change in impedance over the course of 
the 24-hour growth period. The black line corresponds to the sample with bacteria added, and the red line 




Figure 5-6: LIVE/DEAD stain identifying biofilm growth in microfluidic channel. Dark areas correspond 
to electrodes. Area encircled in yellow is the sparse biofilm aggregate. 
5.3.4 Additional environments vulnerable to biofilm colonization 
The system developed in this work has the potential to address challenges in many 
environments beyond urinary catheters. Biofilm presents a significant issue in healthcare [23], 
food production [198], water systems [199], [200], and marine [201] environments. Notably, it 
would be relatively straightforward to adapt this system for use in hospital water pipes and sinks, 
which can lead to outbreaks among vulnerable populations when they are colonized by Legionella 
pneumophila or Pseudomonas aeruginosa [202]–[204]. This would simply involve scaling the 
device to the appropriate dimensions and calibrating it for use in water. I would expect this system 
to be simpler than that for the urinary catheter, as urine is more variable and there are more design 
constraints for indwelling medical devices. The sensing and treatment approach could also be 
adapted for use with indwelling vascular catheters, which are often colonized by biofilm [205]. 
This would involve scaling down the system, as vascular catheters are typically smaller than 
urinary catheters. Careful considerations also need to be made as vascular catheters can become 
occluded due to thrombus formation [206]. 
5.4 Conclusion 
CAUTI remains a widespread challenge in healthcare despite various efforts to reduce its 
incidence and impact. Microsystem technologies offer a novel approach for both identifying 
infection risk due to biofilm growth and eliminating biofilm from the surface of a urinary catheter 
in a small form factor. This dissertation details the development of a microsystem-based biofilm 
management system from a flexible proof-of-concept device to an integrated system validated 
under realistic conditions in vitro. I utilized a flexible substrate with microfabricated IDEs to 
achieve real-time detection via electrochemical impedance sensing and administer an electric field 
120 
 
for BE treatment while conformed in a cylindrical catheter shape. I then leveraged commercial 
microelectronics and 3D-printing to create a functional integrated prototype, which was 
subsequently evaluated in a customized in vitro bladder model. This is the first demonstration of 
each of these functionalities with respect to CAUTI and indwelling catheters. Importantly, this is 
the first implementation of a microsystem-based approach for biofilm detection and treatment on 
urinary catheters. Recent research has typically focused on novel materials and surface 
modifications. I anticipate that the system investigated in this dissertation can function 
synergistically with these other strategies to achieve a reduction in CAUTI incidence. 
The research in this dissertation has the potential to generate new kinds of data when 
evaluating CAUTI for future research and in the clinical setting. The real-time, in situ information 
yielded by this device is unique for these infections and can have far-reaching implications for 
how biofilms are studied in this context. In addition, the in vitro testing model represents a viable 
technique for evaluating future catheter-based devices and systems, thus establishing a 
methodology for developing future devices in this space. The initial microsystems demonstration 
in this dissertation serves as the baseline for developing a multitude of different microsystems for 
addressing CAUTI. Furthermore, this work can have an impact beyond CAUTI. The developed 
integration strategies can be implemented for an array of microelectronic sensors for various 
applications involving non-planar surfaces, particularly in healthcare and biomedical research. 
Overall, the approach developed in this dissertation will facilitate future biofilm research by 
generating continuous in situ impedance sensing data and the integration effort supports the future 





6.1 Appendix A: Photomask Patterns 
A.1 Flexible IDEs with 300 µm finger width and spacing 
 
Figure 6-1: Transparency photomask for flexible IDEs. The finger width and spacing is 300 µm over a 10 
mm x 40 mm footprint. Leads are an additional 30 mm x 0.5 mm. Contact pads are 3 mm x 3 mm. Scale 




A.2 Flexible IDEs used within integrated system 
 
Figure 6-2: Transparency mask for flexible IDEs. Finger width/spacing is 300 µm over a 9.8 mm x 40 mm 
footprint. Leads 0.5 mm wide, connecting to 2 mm x 2 mm contact pads positioned 0.5 mm or 4.5 mm from 




A.3 IDE array device 
 
Figure 6-3: Transparency photomask of array device for biofilm mapping. Traces are 300 µm 
wide and contacts are 2 mm x 2 mm. 8 IDE pairs are evenly spaced over a 9.8 mm x 40 mm 
footprint with 300 µm finger width and spacing. Each device connects with a common ground. 




6.2 Appendix B: Matlab Programs 
B.1 EIS Results 
filepath = 'C:\Users\Ryan\Box Sync\4-channel_4\'; % Enter your data 
folder path 
filepath_temp = 'C:\Users\Ryan\Box Sync\Temp\'; %Enter filepath for 
temp files 
 
startPBS = 1; % start file number of PBS 
endPBS = 1; % end file number of PBS 
  
start_date = 27; %enter start date  
start_hour = 13; % enter starting hour in 24 hour format 
start_min = 10; % enter starting minute 
  
end_date = 27; %enter end date  
end_hour = 13; % enter end hour in 24-hour format 
end_min = 13; % enter end minute 
 
N= endPBS-startPBS+1; % N= number of txt files/runs of the CHI 
M = 60; % M = number of numeric lines in each CHI output text file 
  
Total_time =  (end_date - start_date) * 24 * 60 * 60 + (end_hour - 
start_hour)* 60 * 60 + (end_min - start_min) * 60 ; % Calculate total 
time in seconds 
  
Time_step = Total_time/(N-1); % average step time in seconds between 
two consecutive runs 
  
Time_s = 0: Time_step: Total_time; % create an array called time 
Time_h = Time_s/(60*60); % row array of time in hours 
Final_time = Time_h'; % column array of time in hours 
  
Final_data = zeros(M,5*N); %size of final data array 
Final_realZ = zeros(M,N); %size of final real Z data array 
Final_imZ = zeros(M,N); %size of final im Z data array 
Final_absZ = zeros(M,N); %size of final abs Z data array 
Final_phase = zeros(M,N); %size of final phase of Z data array 
 
j= 1; % counter 
column = 1; % counter for column of final arrays 
for i = startPBS:endPBS 
    filename = [filepath 'endcond' num2str(i) '.txt']; %give path to 
files you want to analyze 
    fid = fopen(filename, 'r') ;                  % Open source file. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
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    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    buffer = fread(fid, Inf) ;                    % Read rest of the 
file. 
    fclose(fid); 
  
    filename2 = [filepath_temp 'endcond' num2str(i) '_TRUNC.txt'];  
    fid = fopen(filename2, 'w')  ;   % Open destination file. 
    fwrite(fid, buffer) ;            % Save to file without header. 
    fclose(fid) ; 
  
    %copy each file content into a temporary array named Temp 
    fileID = fopen (filename2, 'r'); 
    formatSpec = '%f, %f, %f, %f, %f'; 
    sizeTemp = [5 M]; 
    Temp = fscanf(fileID, formatSpec, sizeTemp); 
    fclose(fileID); 
    Transpose_Temp = Temp'; 
     
    % Array frequency contains a column array of the frequencies at 
which measurements were obtained 
    for x=1:M 
        Frequency(x,1) = Transpose_Temp(x,1);  
        x=x+1; 
    end 
     
    %append contents of the array Temp to the final data arrays 
    for x=1:M  
        shift_y=j; 
        for y=1:5 
        Final_data(x,shift_y) = Transpose_Temp(x,y); 
        y=y+1; 
        shift_y=shift_y+1; 
        end 
    end 
    j = j+5; % increment counter by 5 columns 
     
    % Write into individual arrays 
    for a=1:M 
        Final_realZ(a,column)= Transpose_Temp(a,2); 
        Final_imZ(a,column)= Transpose_Temp(a,3); 
        Final_absZ(a,column)= Transpose_Temp(a,4); 
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        Final_phase(a,column) = Transpose_Temp(a,5); 
        a=a+1; 
    end 
      column = column+1; 
end 
  
% plot figure   
  
Avg = mean([Final_data3(:,4) Final_data31(:,4) Final_data32(:,4)],2); 
% find average of multiple sweeps 
 
e1 = std([Final_data3(:,4) Final_data31(:,4) Final_data32(:,4)],1,2); 




% only plot every fifth error bar 
 
% Abs Z versus frequency on a log log scale 
figure 
loglog(Frequency,Avg(:,1), 'r','LineWidth', 2.0) 
hold on 
errorbar(Frequency,Avg(:,1),e1_2, 'r') 
title('Abs Z v. f', 'FontSize',20,'FontWeight','bold') 
xlabel('f', 'FontSize',20,'FontWeight','bold') 
ylabel('Abs Z', 'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 AbsZ_vs_Freq 
hold off 
 
%delete the _TRUNC temp files in the TEMP folder 
 delete('C:\Users\Ryan\Box Sync\Temp\*_TRUNC.txt'); 
  
 
B.2 Equivalent Circuit Fitting 
% Impedance Equivalent Circuit Fitting 
 
% Plot experimental value 
  
filepath = 'C:\Users\Ryan\Box Sync\Biofilm Exp 04102017\'; % Enter 
your data folder path 
filepath_temp = 'C:\Users\Ryan\Box Sync\Temp\'; %Enter filepath for 
temp files 
  
startPBS = 1; % start file number of PBS 
endPBS = 1; % end file number of PBS 
  
start_date = 27; %enter start date  
start_hour = 13; % enter starting hour in 24 hour format 




end_date = 27; %enter end date  
end_hour = 13; % enter end hour in 24-hour format 
end_min = 13; % enter end minute 
  
N= endPBS-startPBS+1; % N= number of txt files/runs of the CHI 
  
M = 60; % M = number of numeric lines in each CHI output text file 
  
Total_time =  (end_date - start_date) * 24 * 60 * 60 + (end_hour - 
start_hour)* 60 * 60 + (end_min - start_min) * 60 ; % Calculate total 
time in seconds 
  
Time_step = Total_time/(N-1); % average step time in seconds between 
two consecutive runs 
  
Time_s = 0: Time_step: Total_time; % create an array called time 
Time_h = Time_s/(60*60); % row array of time in hours 
Final_time = Time_h'; % column array of time in hours 
  
Final_data = zeros(M,5*N); %size of final data array 
Final_realZ = zeros(M,N); %size of final real Z data array 
Final_imZ = zeros(M,N); %size of final im Z data array 
Final_absZ = zeros(M,N); %size of final abs Z data array 
Final_phase = zeros(M,N); %size of final phase of Z data array 
  
j= 1; % counter 
column = 1; % counter for column of final arrays 
for i = startPBS:endPBS 
    filename = [filepath 'ch6endseed' num2str(i) '.txt']; %give path 
to files you want to analyse num2str(i) removed for this 
    fid = fopen(filename, 'r') ;                  % Open source file. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    fgetl(fid) ;                                  % Read/discard line. 
    buffer = fread(fid, Inf) ;                    % Read rest of the 
file. 




    filename2 = [filepath_temp 'ch6endseed' num2str(i) '_TRUNC.txt']; 
%num2str(i) 
    fid = fopen(filename2, 'w')  ;   % Open destination file. 
    fwrite(fid, buffer) ;            % Save to file without header. 
    fclose(fid) ; 
  
    %copy each file content into a temporary array named Temp 
    fileID = fopen (filename2, 'r'); 
    formatSpec = '%f, %f, %f, %f, %f'; 
    sizeTemp = [5 M]; 
    Temp = fscanf(fileID, formatSpec, sizeTemp); 
    fclose(fileID); 
    Transpose_Temp = Temp'; 
     
    % Array frequency contains a column array of the frequencies at 
which measurements were obtained 
    for x=1:M 
        Frequency(x,1) = Transpose_Temp(x,1);  
        x=x+1; 
    end 
     
    %append contents of the array Temp to the final data arrays 
    for x=1:M  
        shift_y=j; 
        for y=1:5 
        Final_data(x,shift_y) = Transpose_Temp(x,y); 
        y=y+1; 
        shift_y=shift_y+1; 
        end 
    end 
    j = j+5; % increment counter by 5 columns 
     
    % Write into individual arrays 
    for a=1:M 
        Final_realZ(a,column)= Transpose_Temp(a,2); 
        Final_imZ(a,column)= Transpose_Temp(a,3); 
        Final_absZ(a,column)= Transpose_Temp(a,4); 
        Final_phase(a,column) = Transpose_Temp(a,5); 
        a=a+1; 
    end 
      column = column+1; 
end 
  
% Abs Z versus frequency on a log log scale 
figure 
syms x y % Set variables 
  
Rs=37; % Solution resistance (ohms) 
Rb=4; % Biofilm resistance (ohms) 
Cd=0.000018; % Interfacial capacitance (F) 
Cb=0.000012; % Biofilm capacitance (F) 
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% Circuit parameter values 
 
x=linspace(10,1000000,1000); % Frequency range and number of points 
y=(Rs+Rb+(2./(6.28*x*Cd))+(1./(x*Cb))); % Series circuit model  








6.3 Appendix C: Mobile Application 
C.1 Measurement Parameters 
Parameter Value 
RFB 250 Ω 
Gain Factor 3.284732484 * 10-6 
Threshold 0% 
Table 6-1: Measurement parameters for wireless sensing using the PCB. 
C.2 Representative Export File 
 
Table 6-2: Representative export file from mobile application including device name, time stamp, 
command, impedance values, phase angle, and calculated percent change. 
  
ID  DeviceName D viceAddress R alImpedence ImaginaryImpedence I pedence PctChange Phase  CommandType im Stamp RealRaw  ImaginaryRaw RealAdjusted ImaginaryAdjusted
1780  Bf DEV  00000000-0000-0000-0000-000d6f910e82-161 -489 647.4726  1.252731  Initial Measurement 2/19/2020 12:15:04 PM5FFF  17FE  FF5F  FE17
1781  Bf DEV  00000000-0000-0000-0000-000d6f910e82      Device Disconnected 2/19/2020 12:15:35 PM0x0000  0x0000  0x0000  0x0000
1782  Bf DEV  00000000-0000-0000-0000-000d6f910e81      Device Connected 2/19/2020 12:16:17 PM0x0000  0x0000  0x0000  0x0000
1783  Bf DEV  00000000-0000-0000-0000-000d6f910e81-749 -482 374.2426 -42.1995 0.57181  Biofilm Forming 2/19/2020 12:16:57 PM3FD  1EFE  FD13  FE1E
1784  Bf DEV  00000000-0000-0000-0000-000d6f910e81-749 -485 373.5602 -42.3049 0.574637  Biofilm Forming 2/19/2020 12:20:53 PM3FD  1BFE  FD13  FE1B
1785  Bf DEV  00000000-0000-0000-0000-000d6f910e81      Device Disconnected 2/19/2020 12:21:23 PM0x0000  0x0000  0x0000  0x0000
1786  Bf DEV  00000000-0000-0000-0000-000d6f910e82      Device Connected 2/19/2020 12:22:23 PM0x0000  0x0000  0x0000  0x0000
1787  Bf DEV  00000000-0000-0000-0000-000d6f910e82-4 -220 149 .712 130.2355 1.390943  Take Measurement 2/19/2020 12:22:31 PMD8FF  24FF  FFD8  FF24
1788  Bf DEV  00000000-0000-0000-0000-000d6f910e82-16 -490 646.6704 -0.1239 1.255181  Biofilm Forming 2/19/2020 12:22:55 PM60FF  16FE  FF60  FE16
1789  Bf DEV  00000000-0000-0000-0000-000d6f910e82-118 -578 565.0464 -12.7305 1.369411  Biofilm Forming 2/19/2020 1:19:43 PM8AFF  BEFD  FF8A  FDBE
1790  Bf DEV  00000000-0000-0000-0000-000d6f910e82-14 -660 4 4.0576 -23.6944 1.361773  Biofilm Forming 2/19/2020 2:16:01 PM74FF  6CFD  FF74  FD6C
1791  Bf DEV  00000000-0000-0000-0000-000d6f910e82-137 -666 4 0.2358 -24.2847 1.367921  Biofilm Forming 2/19/2020 3:16:50 PM77FF  66FD  FF77  FD66
1792  Bf DEV  00000000-0000-0000-0000-000d6f910e82-143 -675 483.105 -25.386 1.362031  Biofilm Forming 2/19/2020 4:56:01 PM71FF  5DFD  FF71  FD5D
1793  Bf DEV  00000000-0000-0000-0000-000d6f910e82-14 -678 48 .4845 -25.6363 1.367169  Biofilm Forming 2/19/2020 5:24:26 PM74FF  5AFD  FF74  FD5A
1794  Bf DEV  00000000-0000-0000-0000-000d6f910e82-17 -733 442.9942 -31.581 1.342902  Biofilm Forming 2/20/2020 7:42:49 AM56FF  23FD  FF56  FD23
1795  Bf DEV  00000000-0000-0000-0000-000d6f910e82-168 -732 443.8341 -31.4513 1.345195  Biofilm Forming 2/20/2020 8:11:33 AM58FF  24FD  FF58  FD24
1796  Bf DEV  00000000-0000-0000-0000-000d6f910e82-173 -736 440.8828 -31.9071 1.339933  Biofilm Forming 2/20/2020 9:13:26 AM53FF  20FD  FF53  FD20
1797  Bf DEV  00000000-0000-0000-0000-000d6f910e82-175 -738 439.4842 -32.1231 1.337969  Biofilm Forming 2/20/2020 10:11:04 AM51FF  1EFD  FF51  FD1E
1798  Bf DEV  00000000-0000-0000-0000-000d6f910e82-173 -739 439.1862 -32.1692 1.340837  Biofilm Forming 2/20/2020 11:12:02 AM53FF  1DFD  FF53  FD1D
1799  Bf DEV  00000000-0000-0000-0000-000d6f910e82-179 -745 435.0461 -32.8086 1.334998  Biofilm Forming 2/20/2020 12:05:47 PM4DFF  17FD  FF4D  FD17
1800  Bf DEV  00000000-0000-0000-0000-000d6f910e82      Treatment Initiated 2/20/2020 12:16:27 PM0x0000  0x0000  0x0000  0x0000
1801  Bf DEV  00000000-0000-0000-0000-000d6f910e82      Device Disconnected 2/20/2020 12:16:35 PM0x0000  0x0000  0x0000  0x0000
1802  Bf DEV  00000000-0000-0000-0000-000d6f910e82      Device Connected 2/21/2020 12:08:49 PM0x0000  0x0000  0x0000  0x0000
1803  Bf DEV  00000000-0000-0000-0000-000d6f910e82      Device Shutdown 2/21/2020 12:08:54 PM0x0000  0x0000  0x0000  0x0000
1804  Bf DEV  00000000-0000-0000-0000-000d6f910e82-64 -642 516.65 -20.2051 1.471436  Biofilm Forming 2/21/2020 12:09:01 PMC0FF  7EFD  FFC0  FD7E
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